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ABSTRACT 
Ionotropic glutamate receptors mediate most of the fast synaptic neurotransmission in 
mammalian central nervous system. These glutamate-gated receptors are oligomeric cation 
channels dived into three pharmacological subclasses; AMPA kainate and NMDA receptors. 
The AMPA receptors are oligomeric assemblies of subunits GluR-A-D. Each subunit has two 
~150 residues sized segments, S1 and S2, which form an extracellular binding site for the 
transmitter (agonist). These ligand-binding segments can be expressed as a soluble fusion 
protein (S1S2), which is able to bind ligands with the same pharmacological profile as intact 
membrane associated receptor.   
In the present study, we used the S1S2 fusion protein of the GluR-D in order to study 
the basis of redox modulation phenomena of iGluRs. By using redox agents and protein 
labelling we showed that a disulfide bridge is formed between Cys-740 and Cys-795 of the 
S1S2 protein. The breakage of the bridge by mutation increased ligand affinity of the S1S2 
protein and caused oligomerization of the protein suggesting that the bridge is important for 
the stability of unliganded structure of the ligand-binding domain. 
We further used the GluR-D S1S2 fusion protein in order to study the structural 
determinants responsible for agonist and antagonist binding. Since the S1S2 region has weak 
sequence similarity to several bacterial amino acid binding proteins it has been suggested that 
the recognition of amino acid ligands is similar in these proteins. In order to test this 
hypothesis, we used sequence alignment of bacterial amino acid binding proteins with the 
GluR-D S1S2 to select residues for site-directed mutation. Analysis of the ligand-binding 
profile of the mutated S1S2 proteins revealed that residues Arg-507 and Glu-727 are 
necessary for agonist binding. Our molecular model demonstrated that these residues interact 
with the α-aminocarboxylate core of the amino acid ligand in a similar manner to the 
corresponding residues in PBPs.  
Additional determinants of agonist binding were found by alanine scanning 
mutagenesis of seven residues in the S2 N-terminal segment. Ligand-binding analysis of 
mutated proteins revealed that mutations L672A, G675A and T677A selectively affected 
agonist binding, leaving antagonist binding intact. This data was supported by subsequently 
published crystal structures of the GluR-B S1S2 in complex with ligands. Our GluR-D S1S2 
ligand docking models were based on the above crystal structures. Together these structural 
models showed that the distal anionic group of the agonist was bound by Tyr-677. In addition, 
our model showed the direct participation of Leu-672 and Gly-675 in agonist binding. Since 
antagonists, which are able to prevent receptor activation, do not seem to form interactions 
with this region, the N-terminal segment of S2 may have particular importance in AMPA 
receptor activation. 
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1 INTRODUCTION 
1.1 AMPA selective glutamate receptors 
1.1.1 Synaptic transmission 
Synaptic transmission is a transfer of a signal from one neuron to another at synapses, 
which are specialized contact sites of two neurons. In most synapses, transmission is chemical 
and is mediated via neurotransmitter compounds. Neurotransmitters are released by one cell 
(presynaptic) into the synaptic cleft and bound by the receptor on the subsequent cell 
(postsynaptic). Glutamate is the most abundant neurotransmitter mediating excitatory signals 
in the central nervous system (CNS). Glutamate activates two types of glutamate receptors: 
ionotropic (iGluRs) and metabotropic glutamate receptors (mGluRs) (Nakanishi, 1992). 
Ionotropic glutamate receptors have been subdivided into α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) 
receptor subclasses according to their ligand specificity and primary structure. Ionotropic 
GluRs mediate fast transmission via an intrinsic cation channel, whereas mGluRs are coupled 
via G proteins and second messenger cascade to ion channels and mediate slower responses to 
glutamate (Anwyl, 1999) At iGluRs, glutamate binding leads to opening of the receptor 
channel and to flow of Na+ and K+ ions down their electrochemical gradients. As a 
consequence of the conductance changes excitatory postsynaptic potentials (EPSP) are 
generated, shifting the resting membrane potential (~-40−-90 mV in neurons) towards more 
positive values. These local depolarizations of membrane potential in turn promote the 
generation of a new action potential in the postsynaptic cell. 
1.1.2 AMPA receptor physiology 
Glutamate receptors exist in every part of the mammalian brain and different 
glutamate receptor subclasses can co-exist in the same cell (reviewed in Dingledine, et al., 
1999). Functional properties of glutamatergic neurotransmission seem to be dependent on the 
iGluRs present in the synapses. The study of native and recombinant glutamate receptors have 
revealed that glutamate receptor subclasses have differences in time course of receptor 
activation and desensitization, in neurotransmitter affinities, and in ion permeabilities, which 
all have their own effect on the time course of signalling  (reviewed in Jonas, 2000; Borges 
and Dingledine, 1998). 
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The binding of agonist (Clements, et al., 1998) leads to opening of the ion channel. 
Normally, glutamate is rapidly removed from synaptic cleft, which leads to rapid closure of 
the channel by deactivation (reviewed in Jonas, 2000). In the continuous presence of 
glutamate, the channel is closed by desensitization, which is particularly fast and strong for 
AMPA receptors and approximately three fold slower (~1-6 ms) than deactivation (Table I). 
AMPA receptor activation occurs with the time constant of sub-milliseconds, whereas 
deactivation occurs in the time scale of one or two milliseconds (reviewed in Jonas and 
Sakmann, 1992). However, slower AMPA receptor evoked excitatory postsynaptic currents 
(EPSCs) have been identified from particular cells (reviewed in Jonas, 2000). NMDA 
receptors are activated with a time scale of 10-50 milliseconds. The deactivation and 
desensitization also occurs with a much slower time course (in the time scale of tens or 
hundreds of milliseconds) than in AMPA receptors (reviewed in Dingledine et al., 1999). 
AMPA and NMDA receptors have distinct ion permeability properties. Most AMPA 
receptors in the CNS only allow the passage of Na+ and K + ions (Mayer and Westbrook, 
1987; reviewed in Jonas and Burnashev 1995), but NMDA receptors also allow passage of 
Ca2+ into the cell (Table I). However, Ca2+ permeable AMPA receptors have been identified 
in, for example retinal ganglion neurons and cerebellar Bergman glia cells (Zhang et al., 
1995). NMDA receptors are blocked in a voltage-sensitive manner by extracellular Mg2+ ions, 
suggesting that the receptor function is blocked at normal membrane potential (Jahr and 
Stevens, 1990). The voltage-dependent Mg2+ block can be removed by depolarization caused 
by persistent activity of AMPA receptors (Fig. 1). 
Glutamate activates AMPA receptors with lower potency than NMDA receptors 
(reviewed in Dingledine et al., 1999). The EC50 value (the effective agonist concentration that 
gives half-maximal response of ionic currents) of glutamate is ~500 µM for AMPA receptors, 
whereas it is ~400 nM - 2 µM in NMDA receptors, depending on receptor subunit 
composition. NMDA receptor activation is distinct from AMPA receptor activation due to the 
requirement of a co-agonist glycine together with the agonist L-glutamate (Kleckner and 
Dingledine, 1988). 
Obviously, the functional diversity of AMPA and NMDA receptors is critical for 
neuronal function, however the precise roles of these receptors are not known. It seems that 
AMPA receptors, which are rapidly activated and deactivated are the primary mediators of 
fast neurotransmission, whereas NMDA receptor are detectors of coincidence activation and 
are functional only during heavy synaptic signalling (Fig. 1). NMDA receptors allow entrance 
of Ca2+ into cell, which promotes activation of second messenger systems and presumably 
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triggers long lasting changes in cell physiology (reviewed in Seeburg, 1993; Dingledine et al., 
1999). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic presentation of the roles of AMPA and NMDA receptor in excitatory synaptic 
transmission. Most normal synaptic transmission is mediated via AMPA receptors.  During normal transmission 
membrane potential is only slightly depolarized and NMDA receptors are blocked by voltage sensitive Mg2+ 
ions. Frequent AMPA receptor activation leads to depolarization of membrane potential, which removes Mg2+ 
block from NMDA receptors. This leads to elevation of intracellular Ca2+ and subsequent activation of 
intracellular messenger systems  (Adapted from Seeburg et al., 2001). 
 
1.1.3 Synaptic plasticity 
The definition of synaptic plasticity is long lasting changes in the synaptic properties, 
which may occur either during development or during adult life. AMPA and NMDA receptors 
have their own role in synaptic plasticity. The so-called use dependent long-term potentiation 
of synaptic strength (LTP) has been widely studied, since this phenomenon is thought to be 
similar to the elementary mechanism underlining learning and memory. LTP has been studied 
in the hippocampus, a brain region known to be important for the formation of new memories. 
Three separate phases of LTP can be distinguished; induction, expression and maintenance 
(reviewed in Abel and Lattal, 2001). One much studied form of LTP can be generated by a 
brief (1s) high-frequency (100Hz) stimulation of presynaptic hippocampal CA3 pyramidal 
cells, and recorded from postsynaptic pyramidal neurons in the CA1 region. After this 
induction, the excitatory post synaptic response (EPSPs) of CA1 cells is increased to 
constantly maintained level following the stimulus. The induction of LTP has been shown to 
require NMDA receptor function, transient elevation of intracellular Ca2+ levels and 
subsequent activation of calcium/calmodulin kinase II (CaMKII) (reviewed in Sanes and 
Mg2+
Mg2+
Ca2+
Normal signal 
transduction
At depolarized 
potential
 12
Lichtman, 1999). AMPA receptors seem to be responsible for the enhanced synaptic currents 
in the expression phase of LTP, perhaps due to changes in the number of postsynaptic AMPA 
receptors (reviewed in Malinow and Malenka, 2002). AMPA receptors are also thought to be 
involved in another type of use-dependent synaptic plasticity, long-term depression (LTD), 
which decreases synaptic strength in a use-dependent manner. Interestingly, LTD also 
involves Ca2+ mediated second messenger systems and activation of several kinases. 
However, the decrease in synaptic transmission (LTD) is thought to be a result of reduction in 
the AMPA receptor number in the postsynaptic membrane. 
1.2 AMPA receptor ligands  
1.2.1 Design of ligands 
The design of new glutamate receptor ligands aims at development of subtype 
selective agonists and antagonist to be used for clinical purposes and for basic studies on 
receptor structure and function. By definition, an agonist is a compound that produces 
receptor activation, whereas an antagonist is a compound that inhibits the response to an 
agonist. The groups of AMPA receptor ligands considered to have the most potential use for 
clinical use are competitive antagonists and allosteric modulators.  
 Accumulation of glutamate in the synaptic cleft can be toxic to cells. In situations like 
hypoxia or hypoglycemia an excessive amount of glutamate is released at the same time as 
active uptake of glutamate (mainly by glia cells) is disturbed. This causes accumulation of 
glutamate and over activation of glutamate receptors, which eventually leads to neuronal 
death (Choi, 1988). The glutamate excitotoxicity also causes problems in situations like brain 
trauma or ischemic stroke induced by artery occlusion. A number of studies show that 
glutamate excitotoxicity can be prevented by inhibition of receptor activity by using 
antagonists or negative allosteric modulators (reviewed in Lees, 2000). In addition, animal 
studies with AMPA receptor antagonists have shown neuroprotection in ischemic stroke 
models (reviewed in Lees, 2000; Nikam and Kornberg, 2001). Glutamate excitotoxicity also 
seems to be involved in chronic neurodegenerative diseases like Parkinson´s disease, 
Huntington´s disease, Alzheimer´s disease and multiple sclerosis. Therefore these situations 
are considered plausible targets for treatment with AMPA receptor antagonists (Krogsgaard-
Larsen et al., 1996; Lees, 2000). 
On the other hand, positive modulators of AMPA receptor function (´ampakines´) 
have been used to promote LTP and improve encoding of memory (Lynch, 1998). They are 
 13
considered as potential drugs for the treatment of different forms of dementia and 
schizophrenia, and some of these have also been studied in clinical trials  (reviewed in Lees, 
2000). 
However, many problems related to the specificity, selectivity and the side effects of 
the glutamate receptor-targeted drugs will still have to be solved. For the time being no 
glutamate receptor-targeted drugs are used for clinical purposes (reviewed in Lees, 2000). 
1.2.2 Agonists 
L-glutamate (Fig. 2) is a natural agonist for all glutamate receptors in CNS. In 
addition, the endogenous L- aspartate is able to activate NMDA receptors (Patneau and 
Mayer, 1990). Several other amino acids like ibotenic acid, kainate, quisqualate, and 
willardiine are synthesized in plants and mushrooms, which act selectively on AMPA and 
kainate receptors (Krogsgaard-Larsen et al., 1996; Fig. 2). The structures of L -glutamate and 
the other naturally occurring compounds have been systematically varied in order to design 
new highly selective glutamate receptor agonists and antagonists. A key feature of all these 
glutamate receptor agonist structures is that they have an α-aminocarboxylate core and a 
distal anionic group (Watkins et al., 1990; Fig.2). Since the structure of the agonists seems to 
be conserved, it is throught that the binding site of the ligand will also have structures that are 
conserved thoughout the iGluR family. In addition, the AMPA receptor shows strict stereo-
selectivity for the agonists, since only L-enantiomers of the amino acid-like ligands can 
activate the receptor. On the other hand, NMDA receptor can also be activated by NMDA 
(Fig. 2) and they bind co-agonists glycine or D-serine (see chapter 1.3.5.2). 
The structure of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
was designed based on naturally occurring ibotenic acid (Fig. 2). The introduction of AMPA 
facilitated distinction of AMPA and kainate receptors, and the further characterization of 
AMPA receptor pharmacology (Krogsgaard-Larsen et al., 1980). This highly selective agonist 
has a nanomolar affinity to AMPA receptor (Sommer et al., 1990). Despite the overall high 
selectivity, high concentrations of AMPA can activate some kainate receptor subunit 
combinations (Table I; Herb et al., 1992; Swanson et al., 1996; Schiffer et al., 1997). On the 
other hand, kainic acid i.e. kainate  (Fig. 2.) is a relatively nonselective agonist that has only a 
micromolar affinity to AMPA receptors (Boutler et al., 1990). However, the ability to induce 
large non-desensitizing currents at AMPA receptors makes it a potent neurotoxin (Lambolez 
et al., 1991).  At AMPA receptors, the rank order of the agonist potencies is; quisqualate 
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>AMPA>glutamate>kainate. For a typical kainate receptor, the rank order is; kainate> 
quisqualate>glutamate>AMPA (reviewed in Hollmann & Heinemann, 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Structures of some naturally occuring and synthetic amino acids showing effect on AMPA 
receptors. The functional groups involved in agonist binding (α-amino, α-carboxyl and the distal anionic group) 
are shown on glutamate, AMPA and kainate. (Adapted from Bräuner-Osborne et al., 2000) 
 
The structures of AMPA and willardiine (Fig. 2.) have been used as the lead in 
attempts to design compounds that could select between AMPA and kainate receptors. A 
number of AMPA derivatives show a potent agonist and antagonist effects on AMPA 
receptors (Bräuner-Osborne et al., 2000), and the derivatives of willardiines comprise the 
second major group of AMPA receptor agonists (Patneau et al., 1992). Willardiine derivatives 
include a selective AMPA receptor agonist (S)-fluorowillardine as well as selective kainate 
receptor agonists (S)-iodo- and bromowillardiines (Swanson et al., 1998; Wong et al., 1994; 
Jane et al., 1997). Ibotenic acid (Fig. 2.) has been the lead compound for designing 
homoibotenic acid (HIBO) and 2-amino-3-(4-bromo-3-hydroxyisoxazol-5-yl) propionic acid 
(Br-HIBO) (Krogsgaard-Larsen, et al., 1980). The (S)-enantiomer of HIBO is a potent AMPA 
L-glutamate Kainate
Quisqualate
AMPA
DNQX Ro 48-8587
Ibotenic acidWillardiine
α
β
γ δ
α
β
γ δ α
β
γ δ
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receptor agonist, whereas (R)-HIBO is a weak NMDA receptor agonist (Krogsgaard-Larsen et 
al., 1996). Interestingly, Br-HIBO has shown discrimination between different AMPA 
receptor subunits (Nielsen et al., 1998). 
1.2.3 Antagonists 
A competitive antagonist prevents receptor activation by displacing the agonist 
compounds. One group of AMPA receptor antagonists is the quinoxaline-2,3-dione 
compounds, which have high affinity and selectivity (Nikam et al., 1999; reviewed in Nikam 
and Kornberg, 2001; Lees, 2000).  6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 6,7-
dinitroquinoxaline-2,3-dione (DNQX) (Fig. 2) were the first compounds developed in this 
series and introduction of these antagonists facilitated the discrimination AMPA and kainate 
receptors from NMDA receptors. However, CNQX and DNQX are almost equally effective at 
AMPA and kainate receptors. In addition, most quinoxaline-2,3-diones have comparatively 
high affinity to the glycine-binding site of NMDA receptors (reviewed in Lees, 2000).  
One derivative of quinoxalinedione structure is 9-midazol-1-yl-8-nitro-2,3,5,6-
tetrahydrotriazolo (Ro 48-8587) which is a relatively new and potent AMPA receptor 
antagonist (Fig. 2). This compound shows 100-fold selectivity for AMPA over kainate 
receptors (Mutel et al., 1998). A number of antagonists are acidic amino acids having longer 
backbone than generally found in glutamate receptor agonists. This group includes a number 
of tricyclic compounds and derivatives of AMPA, which are unselective AMPA or kainate 
receptor antagonists (Krogsgaard-Larsen et al., 1991; Wahl et al., 1992; reviewed in Lees, 
2000). For example, (R,S)-2- amino-3-[5tertbutyl-3-(carboxymethoxy)-4-isoxazolyl]propionic 
acid (ATOA) and (R,S)-2-2amino-3-[5tertbutyl-3-(phosphonomethoxyl)-4-isoxazolyl 
(ATPO) are AMPA receptor inhibitors, but they also act as partial agonists for some kainate 
receptors (Wahl et al., 1998 ). 
1.2.4 Allosteric modulators 
Allosteric modulators are compounds that modulate receptor activation by binding to a 
site distinct from the agonist site. These are either positive modulators, which   enhance 
receptor activity, or negative modulators, which inhibit receptor activation.  
The 2,3-benzodiazepines such as GYKI 52466 and GYKI 53655 are selective 
inhibitors of AMPA receptor responses with minimal effects on kainate receptors (Bräuner-
Osborne et al., 2000). Binding of the GYKI compounds does not compete with the binding of 
positive allosteric modulators aniracetam and cyclothiazide (Johansen et al., 1995; Partin et 
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al., 1996).  Recently, a novel AMPA receptor allosteric antagonist CP-526,427 has been 
described which competes with the  2,3-benzodiazepine compounds and has a high nanomolar 
affinity to AMPA receptors (Menniti et al.,  2000). 
 Most of the positive allosteric modulators of AMPA receptor function belong to two 
structural groups; thiazide derivatives (cyclothiazide [CTZ] and diazoxide) and 
benzoylpiperidine derivatives (aniracetam, benzoylpyrrolidines), also known as “ampakines”. 
These compounds seem to extend the duration of channel activation by blocking 
desensitization (Vyklicky et al., 1991). CTZ is a potent and extensively studied positive 
modulator, which shows remarkable selectivity for so called the flip-splice variants (see 
chapter 1.3.3.) of the AMPA receptor subunits (Partin et al., 1994; 1995). Aniracetam (a 
benzoylpyrrolidine) is less potent than CTZ and potentiates the glutamate-induced currents 
more efficiently in the flop-forms rather than in the flip-forms (Johansen et al., 1995). Further 
derivatives of aniracetam, such as 4-[phenylsulfonylamino)ethylthiol]-2,6-difluoro-
phenoxyacetamide (PEPA) is more potent and selective for the flop-splice variant to varying 
degrees (Sekiguchi et al., 1997). Some derivatives of aniracetam are studied because of their 
ability to enhance memory and ability to enter the central nervous system in an active form 
(reviewed in Lynch, 1998). Potassium thiocyanate (KSCN) is another positive allosteric 
modulator of AMPA receptor current responses, and it is also known to enhance AMPA 
binding affinity in radioligand-binding assays (Honore and Drejer, 1988). The affinity effect 
is likely due to the KSCNs ability to convert receptor into desensitized state (Bowie´and 
Smart, 1993). It has been suggested that CTZ and KSCN, which have opposite effects on 
AMPA receptor desensitization, compete in binding to the same site (Donevan and Rogawski, 
1998).  
Open channel blockers are compounds that inhibit receptor activation by binding 
directly to the channel, after activation of the receptor has made the binding site available. 
This group includes natural polyamines and the derivatives found in the venom of arthropods. 
The argiotoxin and joro toxin selectively blocks the ion flow through AMPA receptors  
(Herlitze et al., 1993; Iino et al., 1996). The binding of these toxins and of the endogenous 
cytoplasmic polyamines spermidine and spermine, are dependent on the structure of ion 
channel forming segment M2 (Herlize et al., 1993; Washburn and Dingledine, 1996; see 
chapter 1.3.5.3).  
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1.3 Stucture of the iGluRs 
1.3.1 Oligomeric structure of the receptor 
Early purification and immunoprecipitation studies with native glutamate receptors 
showed that, like other ion channels, glutamate receptors are multimeric proteins consisting of 
several subunits (Chang et al., 1991; Wenthold et al., 1991; 1996; Blackstone et al., 1992). In 
addition, determination of the hydrodynamic size of the purified preparations by 
centrifugation through sucrose gradient and studies using chemical cross-linking of subunit 
structures suggested that the native receptors consist of four or five subunits (Brose et al., 
1993; Blackstone et al., 1992; Wenthold et al., 1991; Kuusinen et al., 1999). More recently, 
an analysis of purified recombinant receptors either using subunit or tag specific antibodies or 
by electron microscopic imaging, yielded results consistent with pentameric or tetrameric 
structure (Hawkins et al., 1999; Safferling et al., 2001). Moreover, electrophysiological 
analysis of receptor combinations of the wild-type GluR-A and subunits carrying a sensitivity 
marker for a channel blocker suggested a pentameric structure (Ferrer-Montiel and Montal, 
1996). Measurements of different single-channel current patterns of mixtures containing wild-
type subunits and mutated subunits, which have specific subconductance level, also suggested 
pentameric structure (Premkumar and Auerbach, 1997). However, most of the recent studies 
favour tetrameric stoichiometry for AMPA and NMDA receptors. Studies following dose-
response curves of activation of mutant and wild-type mixtures of NMDA or GluR-A 
subunits, have suggested tetrameric structure (Laube et al., 1998; Mano and Teichberg, 1998). 
Rosenmund et al. (1998) used chimeric non-desensitizing AMPA subunit mutants 
(GluR6/GluR-C) and assumed that the distinct electrophysiological states depended on how 
many of the receptor binding sites have an agonist bound. They further assumed that 
occupancy of the two binding sites is necessary for the channel opening and thus suggested 
that the three measured conductance states implied four sites for agonist binding, one in each 
subunit of the tetrameric assembly. Another functional analysis of chimeric AMPA receptor 
subunits (GluR-A/GluR-6) indicated distinguishable responses of the different combinations 
of heteromeric receptors suggesting that a tetrameric assembly is formed through dimerization 
of subunit monomers (via N-terminal domain) followed by dimerization of two subunit 
dimers (Ayalon and Stern-Bach, 2001). 
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1.3.2 Receptor subunits  
The first glutamate receptor subunit was cloned by injection of the rat brain mRNA 
into Xenopus oocytes, and by probing the expression by measuring electrophysiological 
responses (Hollmann et al., 1989). The first isolated subunit was initially named as GluR-K1 
and later shown to form an AMPA-selective receptor and renamed GluR1 or GluR-A 
(Keinänen et al., 1990; Boutler et al., 1990). The subsequent cloning and characterization of 
other iGluR subunits supported the previous pharmacological classification of receptors into 
three subfamilies (Table I). Currently, 14 iGluR subunits are known, which are considered to 
belong to AMPA, kainate or NMDA receptor subfamily.  
The iGluRs form a receptor superfamily of their own, unlike initially suggested. The 
iGluR subunits are distinct from subunits of nicotinic acetylcholine receptor, γ-aminobutyric 
acid receptorA, glycine receptor and serotonin receptor by size, the conserved sequence 
patterns and by transmembrane topology (1.3.4; reviewed in Sprengel and Seeburg, 1993). 
The subunits of same subfamily (AMPA, kainate and NMDA) have higher amino acid 
identity with each other than with subunits of a different subfamily (Fig. 3). The amino acid 
sequence identity between AMPA receptor subunits (GluR-A –D) is 68-78 %, whereas 
identity to kainate receptor subunits is only ~40 % (Keinänen et al., 1990). A number of 
expression studies have shown that iGluRs are always assembled from subunits belonging to 
the same subfamily. Functional AMPA receptors are homomeric or heteromeric assemblies 
from subunits GluR-A-D (Keinänen et al., 1990; Nakanishi et al., 1990) (Table I). Functional 
homo- or heteromeric kainate-selective receptors are assembled from GluR5-7 (known as 
´low affinity´ subunits), whereas KA1 and KA2 subunits (known as ´high-affinity´ subunits) 
can assemble into functional channels only when GluR5-7 subunits are co-expressed (Table I) 
(Bettler et al., 1992; Werner et al., 1991). In turn, functional NMDA receptors are composed 
of assemblies of the NR1 together with NR2A-D subunits (reviewed in Hollman & 
Heinemann, 1994a)(Table I). However, the NR1 subunits have been shown to form functional 
receptors in Xenopus oocyte expression, although functional homomeric channels have not 
been yielded in mammalian cell line expression (Moriyoshi et al., 1991).   
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Table I. Subunits and characteristics of iGluR channels 
Receptor 
Family
Subunit Alternative 
nomenclature 
RNA 
editing 
Alternative 
splicing 
Functional characteristics 
AMPA GluR-A, α1 GluR1  Flip/flop 
AMPA GluR-B, α2 GluR2 Q/R,R/G Flip/flop, 
C-sp 
AMPA GluR-C, α3 GluR3 R/G Flip/flop 
AMPA GluR-D, α4 GluR4 R/G Flip/flop, 
C-sp 
Rapid kinetics, low Ca2+ 
permeability, Glu activates 
desensitizing current, KA 
activates non-desensitizing 
current (Boutler, et al., 1990; 
reviewed in Fletcher and Lodge, 
1996) 
Kainate GluR5 β1 Q/R N-sp, C-sp 
Kainate GluR6 β2 Q/R,I/V Y/C C-sp 
Kainate GluR7 β3  C-sp 
Kainate KA-1 γ1   
Kainate KA-2 γ2   
Rapid kinetics, Glu and KA 
activate rapidly desensitizing 
current (reviewed in Fletcher 
and Lodge, 1996). AMPA do 
not activate homomers of 
GluR6 or GluR7, but 
heteromeric GluR6/KA2 and 
GluR7/KA1 or GluR7/KA2 
receptors produce slowly 
desensitizing currents (Egebjerg 
, et al., 1991; Shiffer, et al., 
1997; Herb, et al., 1992). 
NMDA NR1 ζ1  N-sp, C-sp 
NMDA NR2A ε1   
NMDA NR2B ε2   
NMDA NR2C ε3   
NMDA NR2D ε4   
Slow kinetics, large 
conductance, little 
desensitization, high Ca2+ 
permeability, voltage dependent 
Mg2+ block, glycine as co-
agonist (reviewed in McBain 
and Mayer, 1994). 
 NR3A    Chatterton et al., 2002 
 NR3B     
Orphan δ1    
Orphan δ2    
Do not form functional channels 
by themselves 
KA = kainic acid, Glu = glutamate, Flip/flop = 38 aminoacid cassette, C-sp = C-terminal splicing, N-sp 
= N-terminal splicing. AMPA receptor subunits GluR-A-D (Keinänen et al., 1990; Hollmann et al., 1989; 
Boutler et al., 1990; Nakanishi et al., 1990). GluR5-7 subunits (Bettler et al., 1990; 1992; Egebjerg et al., 1991, 
Sommer et al., 1992; Lomeli, et al., 1992). KA1-KA2 subunits (Werner et al., 1991; Herb et al., 1992; Sakimura 
et al., 1992). NR1-NR2 subunits (Moriyoshi, et al., 1991; Merugo, et al., 1992; Monyer, et al., 1992; Ymazaki, 
et al., 1992. ε1-ε4 subunits (Kutsuwada, et al., 1992; Meguro, et al., 1992; Ikeda, et al., 1992). NR3A-B subunits 
(Ciabarra et al., 1995; Chatterton et al., 2002). δ1- δ2 subunits (Lomeli et al., 1993). 
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Two orphan subunits δ1 and δ2, cloned from rat and mouse, have only a low level of 
amino acid identity to other glutamate receptors (Fig. 3.) and are not able form functional 
channels (Yamazaki et al., 1992; Lomeli et al., 1993). Even more peculiar are the relatively 
recently found NR3A-B subunits that also have only low sequence identity to other iGluR 
subunits (Table I). In co-assembly with NR1 subunits they appear to form a completely new 
type of excitatory glycine receptor (Chatterton et al., 2002). Glutamate receptors have also 
been found in the plant Arabidopsis thaliana and bacteria Synechocystis (Lam et al., 1998; 
Chen et al., 1999). The bacterial glutamate receptor (GluR0) resembles structurally and 
functionally both mammalian iGluRs and potassium channels. This receptor binds glutamate, 
but forms a potassium selective channel (Chen et al., 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Phylogenetic tree showing the sequence identity between the cloned mammalian glutamate 
receptor subunits (Adapted from Bräuner-Osborne et al.,, 2000).  
 
The sizes of AMPA receptor subunits, GluR-A-D, are 881-889 amino acids when 
signal peptides are taken into account (Keinänen et al., 1990; Hollmann et al., 1989; Boutler 
et al., 1990; Nakanishi et al., 1990). The kainate receptors GluR5-7 and the KA1-KA2 
subunits and the NMDA receptor subunit NR1 are about same size. In contrast, NMDA 
receptor NR2 subunits are about 1300 residues long (reviewed in Hollmann & Heinemann, 
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1994). The sequence of all iGluR subunits contains an N-terminal hydrophobic signal 
sequence and four hydrophobic segments (19-27 amino acids) that most likely form three 
membrane-spanning α-helices (M1, M3 and M4) and one membrane re-entrant loop (M2) 
(Fig. 4). The N-terminal half of the AMPA receptor subunits (~400 amino acids) are much 
less conserved than the sequence of the C-terminal half of the subunits. The N-terminal 
segment has several potential consensus sites for N-glycosylation (4-6 in AMPA subunits, see 
Fig. 4.; Keinänen et al., 1990; Everts et al., 1997), whereas the C-terminal half of the AMPA 
subunits has several consensus sites for phosphorylation (Roche et al., 1996).  
 
1.3.3 Molecular diversity  
A number of expression studies have shown that a large diversity in the functional 
properties of glutamate receptors can be achieved by simply varying the subunit composition 
of the receptors (reviewed in Hollmann & Heinemann, 1994). In the native receptors subunit 
composition can be regulated at gene expression level to meet the demands of the 
physiological role of the cell. The functional properties of iGluRs are further increased by 
processing the genome encoded transcription products by alternative splicing or RNA-editing 
(Table I).  
Co-expression studies have shown that the AMPA receptor Ca2+ permeability 
properties are dominated by the GluR-B subunit. Receptors composed of GluR-A, -C and -D 
subunits are highly permeable to Ca2+ and show inward rectification. Incorporation of even 
one GluR-B subunit in the receptor assembly results in formation of Ca2+ impermeable 
channels with a linear current-voltage (I-V) relationship (Hollmann et al., 1991; Verdoorn et 
al., 1991; Burnashev et al., 1992; Bowie and Mayer, 1995). The finding that most of the 
native AMPA receptors have the same characteristics as recombinant receptors containing 
GluR-B subunits, has supported the suggestion that nearly all native AMPA receptors are 
assemblies of GluR-B subunit with the GluR-A, -C or -D subunits (Westbrook and Mayer, 
1987; Partin et al., 1993; Jonas & Burnashev, 1995). On the other hand, a recent co-
expression study of recombinant GluR-A and -B subunits has suggested that the subunits are 
not assembled randomly (Mansour et al., 2001). By studying conductance properties of the 
subunits carrying permeation and conductance markers as function of relative expression 
level, the assembly of two GluR-A subunits together two -B subunits was shown to be more 
favoured than the other assemblies (Mansour et al., 2001). 
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All AMPA receptor subunits have alternative segments, which affect the receptor 
function. The AMPA receptor subunits have two different sites that can be modified by 
alternative exons; the flip/flop-cassette and the C-terminal splice cassettes (Fig. 4). The 
flip/flop region (between M3 and M4 membrane-spanning segments) is found in all GluR-A-
D subunits (Sommer et al., 1990); two alternative exons encode the 38 amino acid flip/flop-
cassettes, which differ by only 9-11 residues. The flip/flop-variants have slight differences in 
ligand-binding properties (Nakanishi, 1992), different desensitization kinetics (Moscbacher et 
al., 1994) and different sensitivity to desensitization modulators CTZ (Partin et al., 1995; 
2001) and PEPA (Sekiguchi et al., 1997). The second splicing site occurs in the C-terminal 
domain of the GluR-B and -D subunits, due to which their C-terminal tails contain either 36 
or 54 residues (Köhler et al., 1994; Gallo et al., 1992).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic presentation of AMPA receptor subunits. The size of the GluR-A-D subunits are 
~900 amino acids. All subunits contain 4-6 potential sites for N-glycosylation (  ץ  ) and four hydrophobic 
membrane segments M1-M4 (black boxes).The ligand binding domain regions S1 and S2 are indicated by 
shading. Different splice variant forms of subunits are shown. AMPA receptors may have flip/flop and C-
terminal (different sized boxes in C-terminus) splice variants. The location of residues altered by RNA-editing 
are at the Q/R- (     )and the R/G  (     ). 
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RNA editing is another mechanism, by which the genome encoded sequence of 
AMPA receptor subunits are altered. The sequence of the pre-RNA is changed by 
deamination of adenosine to inosine (dsRNA adenosine desaminase), which leads to a change 
in one amino acid codon in the protein translation (Higuchi et al., 1993; Liu et al., 1999).  The 
AMPA receptor pre-mRNA can be modified independently at two sites (Fig. 4). The first site 
is found in the second membrane segment (M2) of the GluR-B subunits only (Sommer et al., 
1991). Substitution of a glutamine with an arginine (Q/R-site) affects the Ca2+ permeability 
properties of receptors containing GluR-B subunits, as discussed above. The GluR-A, -C and 
-D subunits occur only in the genomic encoded form (Sommer et al., 1991). The second site 
affected by RNA editing preceds the flip/flop area of GluR-B-D subunits (Fig. 4). Edition at 
this so-called R/G-site leads to substitution of an arginine to a glycine and affects the recovery 
of receptor from desensitization (Lomeli et al., 1994).  
1.3.4 Membrane topology 
Membrane topology studies have tried to characterize which segments of the receptor 
proteins are extra- and intracellular and which segments are embedded in the plasma 
membrane bilayer. Initially, the finding that the subunits contain a N-terminal signal peptide 
and four suitable length hydrophobic segments led to a suggestion that subunits have four 
membrane-spanning α-helices like the members of the ligand-gated superfamily (reviewed in 
Sprengel and Seeburg, 1993). Currently, the revised model suggests three transmembrane 
(M1, M3 and M4) segments together with one re-entrant membrane segment (M2). 
Accordingly, the N-terminal domain and region the between M3 and M4 are suggested to be 
extracellular, whereas the C-terminal domain is thought to be intracellular.    
Evidence for the extracellular localization of the N-terminal domain was provided by 
studies showing the presence of N-glycosylation of endogenous or mutated residues and its 
effect on receptor size. Also tunicamysin was used in order to show prevention of N-
glycosylation  (Hollmann et al., 1994; Wood et al., 1995; Kawamoto et al., 1995a,b). In 
addition, clear indications of N-glycosylation on endogenous and introduced N-glycosylation 
sites have been observed in the segment between M3 and M4 in the gold fish kainate-binding 
protein and in the GluR-A (Roche et al., 1994; Hollman et al., 1994b; Wo and Oswald, 1994; 
1995a). The intracellular localization of the C-terminal domain has also been indicated, since 
the C-terminal domain of all AMPA receptor subunits have potential target sites for proteine 
kinase C (PKC), proteine kinase A (PKA) and Ca2+-and calmodulin dependent protein kinase 
II (CAMKII), and the receptor activity has been shown to be potentiated by these kinases 
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(reviewed in Smart, 1997). These findings were in conflict with the originally postulated four 
membrane-spanning segments based on the hydropathy analysis of subunit amino acid 
sequence. This controversy was solved by a study, which showed that deletion of the M2 
segment did not affect glycosylation of the region between M3 and M4. The data was 
interpreted to suggest that the relatively hydrophilic M2 segment forms a re-entrant loop 
instead of membrane-spanning α-helix (Wo and Oswald, 1994; 1995a). Further support was 
given by a study of the accessibility of the pore lining segments of the AMPA and NMDA 
receptors to sulfhydryl reagents. The pattern of accessibility and the accessibility of the M2 
segment to sufhydryl regents from both sides of the membrane revealed that the stucture of 
M2 might be similar to the structure of the P-loop of K+ channels (Kuner et al., 1996; 2001, 
see chapter 1.3.5.3.).  
1.3.5 Structural domains 
The sequence alignment of iGluR subunits with other proteins has revealed that the 
iGluRs have regions with low but significant sequence identity to bacterial proteins 
(Nakanishi, 1990). Based on these sequence similarities, iGluR subunits can be sectioned into 
an N-terminal domain (O´Hara, 1993), a ligand-binding domain (Stern-Bach, et al., 1994; 
Kuryatov et al., 1994; Kuusinen et al., 1995) and a membrane channel (Wood et al., 1995; 
Chen et al., 1999) (Fig. 5a and 5b). The intracellular C-terminal domain has not been found to 
have significant sequence identity with any bacterial protein. The modular structure of iGluR 
subunits suggests that the independent domains are associated with a certain function, which 
may be similar to the function of the homologous prokaryotic proteins. The multidomain 
structure of iGluRs, like that of numerous other proteins, may have evolved from distinct 
ancestral genes by exon shuffling mechanism.  
1.3.5.1 N-terminal domain (X-domain) 
The amino acid sequence of the N-terminal ~400 residues of iGluR subunits (X-
domain) has distant sequence similarity to the N-terminal domain of the mGluRs and to the 
bacterial leucine (LBP) and the leucine/isoleucine/valine-binding protein (LIVBP) (O´Hara et 
al., 1993) (Fig. 5a). This ´LIVBP-like´ domain also shows resemblance to the N-terminal 
domain of guanylate cyclases and atrial natriuretic peptide receptors (O´Hara et al., 1993). 
Interestingly, the N-terminal domain is entirely absent from the kainate-binding proteins 
(KBPs) of chick, frog and goldfish, which are otherwise similar to iGluR subunits  (Gregor et 
al., 1989; Wo and Oswald, 1994). The recently identified glutamate-activated potassium 
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channel, ´GluR0´ also lacks the N-ternimal domain (Chen et al., 1999). Since the X-domain is 
largely variable in amino acid sequence with and between subclasses of iGluRs, it may have 
subunit specific function.  
The X-domain of AMPA and kainate receptor subunits does not seem to contribute to 
agonist binding properties of the receptor (Everts et al., 1997; Kuusinen et al., 1999), but it 
has been suggested to control the assembly of the subunits (Kuusinen et al., 1999; Leuschner 
and Hoch, 1999; Ayalon and Ster-Bach, 2001). In the NMDA receptors, pH sensitivity, 
glycine-independent desensitization and the regulation of receptor function by compounds 
like polyamines, histamine, Mg2+ and Zn2+, seem to localize or be associated with the X-
domain (reviewed in Dingledine et al., 1999; Zheng et al., 2001).  
1.3.5.2 Ligand-binding domain (S1S2). 
Two separate extracellular regions of  ~150 amino acids each, one (S1) preceding the 
first membrane segment, and the other (S2) locating between the M3 and M4 segments 
together have weak sequence similarity to the bacterial periplasmic glutamine (QBP) and the 
lysine/arginine/ornithine binding protein (LAOBP)(Fig. 5a; Nakanishi et al., 1990; Hsiao et 
al., 1996; O´Hara et al., 1993). These segments also show sesequence similarity to KBPs of 
of chick, frog and goldfish. Studies with chimeric AMPA/kainate and NMDA receptor 
subunits have shown that S1 and S2 regions are important determinats of the ligand 
pharmacology (Stern-Bach et al, 1994; Kuryatov et al., 1994). Further mutation studies have 
supported this view (Paas et al., 1996; Swanson et al., 1997b; Mano et al., 1996). Moreover, 
expression of these segments as soluble S1S2 fusion protein has shown that these regions 
form a protein that can bind ligands with the same pharmacology as intact receptors 
(Kuusinen et al., 1995). Furthermore, crystallization and structure determination of a similar 
AMPA receptor fusion protein confirmed the ligand-binding role of S1S2 and the structural 
relationship of iGluRs and PBPs (Armstrong et al., 1998) (see chapter 1.4.1). More recently, 
functional characterization of the bacterial GluR0 channel (Chen et al., 1999) and subsequent 
crystallization of the corresponding S1S2 –fusion protein, revealed that the 3-dimensional 
structure of the ligand-binding domain of iGluR and GluR0 subunits are highly similar 
(Mayer et al., 2001). 
In addition to ligand binding, the S1S2 contributes to AMPA receptor desensitization 
(see chapter 1.5.2) and redox modulation. Variation of the flip/flop segment in the C-terminal 
part of the S2 has been shown to affect receptor desensitization (Partin et al., 1994; Partin et 
al., 1996; Sekiguchi et al., 1997). In addition, the so-called R/G RNA editing site, which 
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precedes the flip/flop region of the AMPA receptor subunits, is also involved in regulation of 
receptor desensitization (Lomeli et al., 1994).   
The S2 segment of all AMPA receptor subunits contains two Cys residues in 
corresponding to those (Cys-744 and Cys-798) in NMDA receptor NR1 subunit. In the 
NMDA receptors this conserved cysteine pair has been shown to be responsible for redox 
modulation, pH sensitivity and binding of Zn2+ (Sullivan et al., 1994; reviewed in McBain 
and Mayer, 1994). However, AMPA receptors have been shown to be insensitive for redox 
modulation (Aizeman et al., 1989; Terramani et al., 1988). These cysteines have been 
suggested to be important in stabilization of the structure of the ligand-binding domain of the 
iGluRs (Sutcliffe et al., 1996; see chapter 1.4.4).  
In the NMDA receptors, a number of mutation analyses have shown that the S1S2 
region of the NR1 subunit determines the binding of the co-agonist glycine, whereas the same 
region in the NR2 subunits determines the binding of glutamate (Kuryatov et al., 1994; Hirai 
et al., 1996; Laube et al., 1997; Ivanovic et al., 1998). 
1.3.5.3 Transmembrane channel 
The electrophysiological analysis has shown that the RNA editing Q/R-site (see 
chapter 1.3.3) in the M2 segment determines the Ca 2+ permeability of the AMPA channels 
(Hollman et al., 1991; Verdoorn et al., 1991; Hume et al., 1991; Burnashev et al., 1992). This 
strongly suggests that the M2 segment participates in channel formation. All the AMPA 
receptor assemblies, which contain one or several GluR-B subunits are impermeable to Ca 2+ 
and have linear steady state current-voltage relation, since the subunits of the GluR-B are 
edited almost 100% and carry the Arg residue at the Q/R-site (Hume et al., 1991; Verdoorn et 
al., 1991; Burnashev et al., 1992; Dinglenine et al., 1992). Due to the Gln residues at the Q/R-
site of the GluR-A, -C and –D subunits, the receptors assembled from these subunits are 
highly permeable to Ca2+ and show inward rectification.  The rectifying I-V relationship has 
been assigned to a block caused by intracellular polyamines, spermine and spermidine, which 
bind to the Gln at Q/R-site (Bowie and Mayer 1995; Washburn and Dingledine, 1996). 
Similarly, blockage of Ca2+ permeable AMPA receptors by argiotoxin has been assigned to 
the Gln residue at the Q/R site (Herlitze et al., 1993; Meucci and Miller, 1998). 
In addition, the M3 segment of AMPA receptors has been shown to affect gating 
properties of the receptors. The ´Lurcher mice´ have been found to be associated with 
spontaneous mutation of Ala to Thr at a highly conserved C-terminal segment of the M3 in 
the GluRδ2 subunit (Zuo et al., 1997). The corresponding mutation at other AMPA and 
 27
kainate receptor subunits makes the receptors continuously active or renders them to be 
activated by CNQX, normally an antagonist  (Zuo et al., 1997; Taverna et al., 2000; Schwarz 
et al., 2001).  
Sequence comparison of the predicted channel regions of the iGluRs and other 
channels has revealed that these regions have weak similarity to the pore regions of K+ 
channels. This suggests that the ion channels of these proteins are composed of a similar 
module (Wood et al., 1995). The M2 region of the iGluRs was suggested to form a re-entrant 
loop similar to the P-segment of voltage –gated K+ channels for which the tertiary structure 
was known from mutation analysis (Wood et al., 1995; Wo and Oswald, 1995a,b). As 
mentioned, the accessibility profile of Cys-substituted residues of the M2 of the NMDA and 
AMPA receptors supported the view that the M2 segment forms an α-helical structure 
followed by random coil (Kuner et al., 1996; 2001). Determination of the crystallographic 
structure of bacterial potassium channel (KcsA) from Steptomyces lividans confirmed that the 
K+ channel subunit is formed from one re-entrant loop (P-segment) and two membrane-
spanning segments (Doyle et al., 1998). This led to a proposal that the membrane segments 
M1, M2 and M3 of the iGluR subunits correspond structurally to the channel forming regions 
of K+channel subunits (Fig. 5b and 5c). In addition, expression cloning of the bacterial K+ 
permeating glutamate receptor, GluR0, revealed that the regions which likely forms the 
channel of the GluR0 are similar both to the channel regions of other K+channels and to the 
potential channel regions of mammalian iGluR subunits (Chen et al., 1999). Thus, it was 
proposed that the GluR0 receptors have a re-entrant loop and two membrane-spanning 
segments similar to the K+ channels, but the orientation of the channel segments would be 
inverted in the plane of the membrane (Chen et al., 1999; reviewed in Miller, 2000). The 
iGluR subunits were proposed to contain a similar membrane core structure than K+channel 
subunits plus one extra transmembrane segment (M4), which does not exist in the KscA or 
GluR0 proteins (Fig. 5c). 
1.3.5.4 C-terminal domain  
The C-terminal domain of the AMPA receptor subunits has no significant sequence 
similarity to any bacterial or mammalian proteins. The GluR-A subunit has a C-terminal 
domain of 81 amino acids, whereas the C-terminal domain of the GluR-C subunit is only 50 
residues long (Keinänen et al., 1990). The GluR-B and -D subunits have either 68 or 50 
amino acids in their C-terminal domains due to alternative splicing (Köhler et al., 1994; Gallo 
et al., 1992). The C-terminal domain of kainate receptors are of similar size to GluR-A-D 
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subunits, whereas the C-terminal domain of the NMDA receptor NR2 subunits are 
significantly larger, ~ 620-640 amino acids (reviewed in Sprengel and Seeburg, 1993). 
  The C-terminal domain is cytoplasmic and has contacts with proteins of the 
postsynaptic density (PSD). The C-terminal domain of AMPA receptor subunits has several 
potential phosphorylation sites for PKA, PKC and CAMKII  (Roche et al., 1996), and is 
potentially subjected to phosphorylation and dephosphorylation. For example, 
phosphorylation of AMPA receptors by CAMKII has been shown to correlate with increased 
AMPA receptor activity during induced LTP (Barria et al., 1997). In addition, 
phosphorylation is thought to regulate the interaction of the C-terminal domain with PSD-
proteins, which contains PDZ domains (PSD-95/Dlg/ZO1). Variety of of such intracellular 
proteins has been shown by immunoprecipitation studies to interact with the C-terminal 
domain of the AMPA receptors (reviewed in Sheng and Sala, 2001; Malinow and Malenka, 
2002). One of the first identified proteins from this group was glutamate receptor-interacting 
protein (GRIP), which is thought to be involved in AMPA receptor trafficking or in anchoring 
of the AMPA receptors at synapses (reviewed in Sheng and Sala, 2001). A recent nuclear 
magnetic resonance (NMR) study suggests that the structure of the C-terminal tail of the 
GluR-B is not stable in a solution, but is stabilized by interaction with the protein GRIP 
(Zhang et al., 2001). Another protein containing one PDZ domain, the protein interacting with 
C-kinase (Pick1), is suggested to be involved in clustering of AMPA receptors (Xia et al., 
1999). In addition, AMPA receptors (GluR-A) have been shown to be associated with a 
SAP97 protein, which belongs to the different PDZ-domain family (PSD-95 family; reviewed 
in Sheng and Sala, 2001). The C-terminal domain is also known to bind to the N-
ethylmaleimide-sensitive fusion protein, which is thought to be involved in membrane fusion 
events and participate in the insertion of recycled AMPA receptors into the plasma membrane 
Nishimune et al., 1998; Ostein et al., 1998).   
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Figure 5. Illustration of the iGluR domain structure. A; The iGluR and mGluR extracellular N-terminal 
domains are related to bacterial periplasmic binding protein leucine/isoleucine/valine binding protein (LIVBP). 
The extracellular ligand-binding domains are constructed from S1 (light blue) and S2 (blue) segments, that are 
related to bacterial glutamine binding protein (QBP), lysine/arginine/ornithine binding protein (LAOBP) and to 
kainate binding proteins (KBP). B; Eukaryotic iGluRs have regions, which are related to the bacterial glutamate 
receptor GluR0 and to the bacterial potassium channel KcsA. The postulated channel regions M1, M2 and M3 of 
the iGluR subunits have sequence similarity to the M1 M2 and M3 of the GluR0 and to M1, P-segment and M2 
of the KcsA. The extracellular ligand-binding domain S1S2 of the iGluR subunits is related by sequence to the 
ligand binding domain of the GluR0 subunit (Chen et al., 1999). C; The predicted membrane topology of the 
eukaryotic iGluRs, prokaryotic GluR0 and prokaryotic KcsA channel. According to the crystal structure of the 
ligand-binding domains S1S2 of the iGluRs and GluR0, glutamate (yellow) is bound between the bilobed ligand-
binding domain (Armstrong et al., 1998; Armstrong and Gouaux, 2000; Mayer et al., 2001). The schematic 
presentation of the binding domain shows that the S1 segment forms most of the lobe 1 (L1) and the S2 forms 
most of the lobe 2 (L2). In the iGluRs the S1 is connected to the N-terminal domain and the M1, whereas the S2 
is flanking the M3 and M4 segments. The structure of the channel region of the KcsA is presented schematically 
based on the crystal structure (Doyle et al., 1998). The KcsA has two transmembrane α-helical segments plus P-
segment, which forms a re-entrant loop of an α-helical N-terminal structure followed by a C-terminal random 
coil structure. The 3-D structures of the iGluRs and GluR0 channel regions are suggested based on their 
sequence similarity to KcsA. (modified from Miller, 2000).   
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Figure 6.  The crystal structure of the GluR-B ligand-binding domain  (S1S2) solved by Armstrong, et 
al. (1998). The kainate agonist (in blue color) is bound between two lobes of the S1S2 ligand-binding domain. 
Residues that interact with all agonists are highlighted with green colour, but the Arg-506 and Glu-726 are 
colored to show the functional groups of the side-chain groups essential for agonist binding. 
 
1.4 Crystal structure of the S1S2 ligand-binding domain 
1.4.1 S1S2 fusion protein as a model for ligand binding and receptor function 
The extracellular segments S1 and S2 have been used to construct soluble fusion 
proteins (S1S2) to be used in studies on ligand-receptor interaction of AMPA, kainate and 
NMDA receptors (Kuusinen et al., 1995; Lampinen et al., 1998; Keinänen et al., 1998; 
Ivanovic et al., 1998, Miyazaki et al., 1999; Wells et al., 2001). The segments of S1 and S2 
are joined by a linker peptide, replacing the membrane segments M1-M3 of the intact 
receptor. 
(Kuusinen et al., 1995; Keinänen et al., 1998) (Fig. 5b). These S1S2 fusion proteins 
structurally resemble bacterial amino acid binding PBPs, which also have two globular lobes 
connected by a flexible hinge peptides. The use of the S1S2 fusion proteins has made it 
possible to study agonist induced conformational changes of the ligand-binding domains in a 
variety of biochemical studies (Abele et al., 1998; 1999; Jayaraman et al., 2000). In addition, 
the affinity and kinetics of agonist binding have been studied by fluorescence stopped-flow 
techniques using these proteins (Abele et al., 2000). Most importantly, an X-ray analysis of 
crystals of the GluR-B S1S2 fusion proteins in complex with ligands provided the first 
detailed three dimensional structure of a neurotransmitter receptor-ligand complex 
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(Armstrong et al., 1998; 2000). Stable, crystallizable fusion protein was achieved by 
truncation of the original S1S2 fusion protein into S1S2I and S1S2J proteins, which could be 
refolded from inclusion bodies of E. coli (Chen and Gouaux, 1997; Chen et al., 1998; 
Armstrong et al., 1998). 
1.4.2 General structure of the GluR-B ligand-binding domain 
The crystal structures of the GluR-B S1S2I in complex with kainate and the S1S2J 
protein in complex with glutamate, AMPA and DNQX confirmed for the first time that the 
ligand-binding domain of iGluR was formed of two globular lobes (lobes 1 and 2) connected 
by two short stretches of peptides. As was previously predicted by sequence similarity 
(O´Hara et al., 1993; Kuryatov et al., 1994), this structure is overall very similar to the 3-D 
structure of the bacterial histidine binding protein (HBP) and LAOBP (reviewed in Adams nd 
Oxender, 1989 and Oh et al., 1994a; Kang et al., 1991; Oh et al., 1993;). In both the bacterial 
binding proteins and the GluR-B S1S2 the amino acid ligand is bound in a cleft between the 
two lobes (Fig. 6). In GluR-B the lobe 1 is composed of the N-terminal part of S1 and a short 
C-terminal segment of S2, and the lobe 2 is composed mostly of the S2 segment and a short 
C-terminal segment of the S1 (Fig, 5c; Armstrong et al., 1998). Both lobes are composed of a 
central core of the β-pleated sheet surrounded by α-helices. The lobe 1 is formed of six α-
helices: A, B, C and D from the S1 segment, and J and K-helices, which are formed by the S2 
segment. The lobe 2 forms α-helices E, F, G, H and I (Armstrong et al., 1998).  
The domain of GluR-B S1S2 with bound agonist is in a closed-cleft conformation, 
whereas the apo-state (unliganded) conformation has the two binding lobes located more 
distantly to each other (open-cleft conformation). Consistent with other studies, the structure 
showed that the closed-cleft conformation is stabilized by multiple hydrogen bonds, whereas 
the unliganded, open-cleft conformation is less stable (Arinaminpathy et al., 2002; Madden et 
al., 2001). In the agonist-bound structure, most of the stabilizing hydrogen bonds are formed 
between the binding lobes and the agonist. In addition, the residues making direct contacts 
with the agonist are in some cases stabilized by hydrogen bond from residues nearby. 
Moreover, the agonist-bound structures also are stabilized by hydrogen bonds between the 
two binding lobes (interdomain bonds), as well as by water molecules, which contribute to the 
network of interactions. On the other hand, the apo-state, open-cleft conformation, is 
stabilized by intradomain interactions  (Armstrong et al., 1998; Armstrong and Gouaux, 
2000). 
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1.4.3 Direct ligand interactions  
Both the iGluRs and PBPs have α-amino and α-carboxyl groups in their amino acid 
ligands. Therefore, it has been suggested (Kawamoto et al., 1997; Laube et al., 1997, Sutcliffe 
et al., 1996) that the agonist-receptor contacts in the iGluRs are similar to the ligand 
interactions seen in the crystal structures of the PBPs (Kang et al., 1991; Oh et al., 1993; Oh 
et al., 1994a,b; Yao et al., 1994). The crystal structure of the GluR-B S1S2 revealed that the 
agonist α-amino group is bonded to an oppositely charged residue Glu-726 in the lobe 2 
(numbering refer to amino acid residues of the rat GluR-B starting from the first translated 
residue; EMBL/GenBank accession No. M36419) by hydrogen bonds and electrostatic 
interactions (Armstrong et al., 1998). The corresponding Glu or Asp residue of the bacterial 
PBPs or GluR0 interacts with the α-amino group of their ligands (Oh et al., 1993; Oh et al., 
1994a,b; Yao et al., 1994; Mayer et al., 2001). The crystal structure of GluR-B S1S2 showed 
that the negatively charged α-carboxyl group is also bound by electrostatic interactions and 
hydrogen bonds to the positively charged Arg-506 in the lobe 1. This residue also has a 
corresponding one in the LAOBP, HBP, glutamine binding protein (GlnBP) and bacterial 
GluR0 structures (Arg-77, Arg-77, Arg-75 or Arg- 117, respectively; Chen et al., 1999, 
Mayer et al., 2001). Additionally, in the GluR-B S1S2 structure, the agonist α-carboxyl group 
is hydrogen bonded to the backbone of Thr-501 and Ser-675, whereas the α-amino group is 
hydrogen bonded to the side-chain of Thr-501 and to the backbone of Pro-499 (Armstrong et 
al., 1998; Armstrong and Gouaux, 2000). In turn, the distal anionic group of the GluR-B 
agonists is hydrogen bonded to the base of an α-helix (helix F) in the lobe 2 involving the 
side-chain of Thr-676 (AMPA, glutamate and kainate complexes) and the backbone groups of 
Thr-676 and Ser-675 (glutamate and kainate complexes).  
Taken together, in the GluR-B S1S2 structure the side-chains of Thr-501, Arg-506, 
Thr-676 and Glu-726 have direct interactions with all agonists (Fig. 6). In addition the 
backbone (carbonyl group) of Pro-499 makes hydrogen bonds to all agonists and Ser-675 
backbone (carbonyl group) interacts with glutamate and kainate. Hydrogen bond interactions 
with antagonist DNQX are made with the side-chains of Arg-506 and the Thr-501 and with 
the backbone of Thr-501. The agonist binding role of Arg-506 and Glu-726 gets support from 
a number of previous mutations studies, which have shown that amino acid substitutions at 
these sites dramatically reduces or abolishes agonist binding or agonist response of the iGluRs 
(Paas et al., 1996; Mano et al., 1996; Uchino et al., 1992; Wafford et al., 1995; Hirai et al., 
1996; Laube et al., 1997; Kawamoto et al., 1997). Moreover, participation of both these 
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residues in agonist binding has been described in a vibrational spectroscopic study of ligand 
binding to the GluR-D S1S2 (Jayaraman et al., 2000).  
A fundamental finding from the crystal structures of the GluR-B S1S2 protein is that 
the bilobed structure is always more closed with a full agonist (AMPA and glutamate) or a 
partial agonist (kainate) than with an antagonist (DNQX) bound. The rigid structure of DNQX 
seems to prevent the closure of binding domains by directly binding to Thr-707. Kainate 
seems to restrict the lobe closure due to its isoprenyl group, which has van der Waals contacts 
with Leu-671.  Interestingly, kainate receptors which have high affinity to kainate, always 
have a small Val residue in place of the Leu-671 of GluR-B. Since mutation of corresponding 
Leu to a Val or a Thr in the GluR-A subunit has been shown to increase receptor affinity to 
kainate, it has been suggested that the binding domain might be more closed in the mutant 
receptor (Mano et al., 1996; Armstrong et al., 2000). 
1.4.4 Indirect interactions 
All the agonist-bound crystal structures of the S1S2 show that the two binding lobes 
are so close together that a bond between the side-chains of Thr-707 and Glu-423 (in lobe 1 
and 2, respectively) is likely to form. The stabilization of agonist bound structures by this 
interdomain bond was prevented when the antagonist DNQX was directly bound to Thr-707. 
Consistent with the suggested stabilization role, mutation of the kainate receptor GluR5 Ser-
721 to Asn at a site corresponding to Thr-707 has been shown to reduce affinity to AMPA 
and 5I-willardiine (Swanson et al., 1997 and 1998). Moreover, mutations of the AMPA or 
NMDA receptor subunits or of the chicken KBPs at the Gln residue corresponding to Glu-423 
of the GluR-B have been shown to decrease agonist sensitivity or to decrease binding 
affinities of agonists to the receptor (Laube et al., 1997; Mano et al., 1996; Uchino et al., 
1992; Paas et al., 1996). The existence of the Thr-707-Glu-423 bond has also been suggested 
by a model, which was based on a study of GluR-A/GluR-C chimeric mutations. In this study 
a residue corresponding to Tyr-723 of the GluR-B was suggested to result in the feature that 
GluR-Aflop receptors have higher affinity for Br-HIBO and faster desensitization with Br-
HIBO activation than the GluR-Cflop receptors (Banke et al., 2001; Mosbacher et al., 1994). 
This Tyr residue (Tyr-716 in GluR-A) was suggested to be hydrogen bonded via a water 
molecule to both the Br-HIBO and to the bond corresponding Thr-707−Glu-423 of GluR-B 
(Banke et al., 2001). On the other hand, molecular models of the GluR-B in complex with 
kainate and different enantiomers of AMPA, argues that the Thr-707−Glu-423 bond is present 
only when a functionally inactive (R)-AMPA is bound. The latter study suggests that in the 
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presence of (S)-AMPA (in the active form) a hydrogen bond would be formed between Glu-
423 and Tyr-449 (Szárics et al., 2001). 
Two other hydrogen bonds, which are formed only in the fully closed GluR-B S1S2 
structures with bound glutamate or AMPA are likely to be important for the maintenance of 
the ligand-bound conformation and for receptor activation. These bonds are formed between 
residues Ser-673−Gly-472 and Asp-672−water−Tyr-471 (Armstrong et al., 2000). A disulfide 
bond Cys-739–Cys-794 between the two binding lobes of the GluR-B subunit has been 
suggested to stabilize an open apo-state (non-ligand bound) conformation of the binding 
domain in a similar manner to which a disulfide bond is thought to stabilize the domain 
structure of the PBPs (Sutcliffe et al., 1996; Oh et al., 1993). This suggestion is supported by 
studies showing that the agonist affinity is increased by removal of the conserved disulfide 
bond in both the gold fish KBP (Wo et al., 1996) and in the AMPA receptor subunits (Watase 
et al., 1997).  
1.5 Mechanism of AMPA receptor activation and desensitization  
An essential feature of all glutamate receptors is that agonist binding induces activation, 
which is a conformational change in the receptor structure that leads to an opening of the 
transmembrane ion channel. Activation is then followed by channel closing either due to 
inactivation (caused by agonist dissociation) or due to desensitization (caused by continuous 
presence of the agonist) (reviewed in Jonas, 2000). For example, in high frequency 
stimulation, glutamate that is normally rapidly removed by uptake to glia cells or by diffusion, 
may remain in the cleft for prolonged times and cause desensitization of the AMPA receptors. 
Both activation and desensitization are particularly fast in the AMPA receptors (see chapter 
1.1.2) The extent of desensitization of the AMPA receptors depends on the type of agonist. 
For example, L-glutamate and AMPA induce fast desensitisation (with a time scale of 1-6 
milliseconds), whereas kainate does not fully desensitize AMPA receptors. In addition, the 
desensitized-state of the AMPA receptors show increased affinity to agonists, which is also 
the case for the well-characterized nicotinic acetylcholine receptor (Hall et al., 1993). 
Desensitization appers to be a general mechanism of many ligand-gated channels to cut ion 
flow into the cell in the presence of the ligand (Jones and Westbrook, 1996; Katz and 
Thresleff, 1957).  
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1.5.1   Domain closure – mechanism of activation and desensitization 
The detailed mechanisms of activation and desensitization of AMPA receptors are still 
poorly understood. However, it seems that the closure of the ligand-binding domain is 
required for activation and desensitization (Armstrong and Gouaux, 2000). The crystal 
structures of the ligand-bound GluR-B S1S2 show that a full agonist induces full closure of 
the binding domain, whereas a partial agonist induces a smaller domain closure and an 
antagonist will stabilize the ligand-binding core in an open-cleft conformation. The level of 
channel activation seems to be dependent on the extent of domain closure, so that large 
conformational changes are transformed into local arrangements of channel gate regions 
(Armstrong and Gouaux, 2000). In a similar manner, the activation of bacterial PBPs seems to 
require domain closure, since the ligand-bound crystal structures of PBPs are more closed that 
the unliganded structures (Oh et al., 1993; Sun et al., 1998). However, closure of the ligand 
binding-domain seems to be more dramatic in the PBPs than in the iGluRs, since the ligand-
induced closure of the LAOBP and GlnBP structures are 51-56° (Oh et al., 1993; Sun et al., 
1998), whereas the kainate- and AMPA-bound structures of the GluR-B ligand-binding 
domain are closed at 12° and 21° in respect to apo-state structure, respectively (Armstrong 
and Gouaux, 2000). However, another study used the GluR-D S1S2 construct (with a longer 
linker between the S1 and S2 as compared to the one used in the crystallization of GluR-B 
S1S2) and detected almost no closure at all (1.1°) upon agonist binding in the solution 
scattering measurements (Abele et al., 1999). The GluR-D study suggested that activation of 
the iGluRs might not require such a dramatic closure of the ligand-binding domain as is 
required for bacterial PBP activation (Abele et al., 1999). Consistent with that suggestion, a 
molecular dynamics simulation study of the GluR-B ligand-binding domain found that 
activation involves only local conformational changes and not dramatic reorganization of 
binding lobes as suggested by the crystal structure (Arinamipathy et al., 2002). In addition, an 
infrared spectroscopic study of the GluR-D S1S2 protein (with longer linker) detected local 
conformational changes in the secondary structure of the ligand-binding domain. Those 
conformational shifts were always more extensive upon binding of an agonist (Jayaraman, 
2000) than upon binding of partial the agonist kainate or antagonist DNQX and CNQX 
(Madden et al., 2001).  
The mechanism of glutamate receptor activation was initially suggested to follow the 
same mechanism as the activation of bacterial PBPs (Mano et al., 1996). The activation of 
bacterial PBPs was described to involve domain closure by ´venus a fly-trap´mechanism (Oh 
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et al., 1993). Mano et al., (1996) suggested that activation of the iGluRs would require 
interaction of the agonist with the lobe 1, whereas the domain closure and entrance into 
desensitized state would require interaction of the agonist with the lobe 2. However, this 
theory was in conflict with some other studies. For example, in the crystal structure of the 
GluR-B S1S2, the lobe 2 participates in kainate binding, although kainate does not allow full 
desensitization of the AMPA receptors (Armstrong, 1998). Since the kainate-bound structure 
is not fully closed, as AMPA- and glutamate-bound structures are, it seems that 
desensitization but not activation requires full closure of the binding domain (Armstrong and 
Gouaux, 2000). This was supported by a recent study on the activation and desensitization of 
a mutated GluR-A receptor using small and large willardiine agonists (Kizelsztein et al., 
2000).  The willardiine docking models (based on the GluR-B crystal structures), suggested 
that the activated state of the ligand-binding domain would be more open, since it can 
accommodate large-sized willardiines (which do not desensitize AMPA channels), whereas 
the desensitized state would be more closed, since it can only accommodate small-sized 
willardiines (known to be able to desensitize AMPA channels).  
Activation of the AMPA receptors has also been studied by examining the order of 
ligand interactions. Based on analogy with bacterial PBPs, the 3-D structures of the ligand 
complexes and the fast kinetic measurements of agonist binding, it has been suggested that 
agonist binding involves two separate steps. The initial binding of an agonist is suggested to 
involve the lobe 1 and the subsequent interactions with the lobe 2 are thought to involve the 
closure of the two binding lobes. Two slightly different models have been presented. The first 
model is based on the kinetics of agonist binding to a mutated GluR-D S1S2 protein as 
measured by stopped-flow fluorescence methods  (Abele et al., 1999) (the numbers of the 
homologous GluR-B residues are one less than in GluR-D). The initial rapid  ´docking´ step 
was suggested to involve the lobe 1 residues Tyr-472 (directly) and residue Glu-424 
indirectly, corresponding to Tyr-471 and Glu-421 of the GluR-B, respectively. The second 
´locking´ step, was suggested to involve a three-way hydrogen-bonding formation involving 
the agonists α-amino group and the residue Glu-727 (lobe 2) and Thr-502 (lobe 1). In 
addition, the residues Pro-500 and Arg-507 (lobe 1) and residues Thr-677 and Ser-676 (lobe 
2) were also suggested to be involved in the agonist binding.  The formation of the three-way 
hydrogen-bonding network was suggested to be essential for receptor activation.  
The second model, which was based on the comparison of the apo-state and agonist-
bound structures of the GluR-B S1S2 crystals, suggests a slightly different order for the 
binding contacts (Armstrong and Gouaux, 2000). The initial contacts were suggested to 
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involve both the α-amino and α-carboxyl groups of an agonist with the residues Arg-506, 
Thr-501 and Pro-499 (lobe 1) and the residue Glu-726 (lobe 2). Closing of the binding lobes 
was suggested to occur in the second step, upon direct binding of the agonist γ-carboxyl group 
to the base of helix F.  
As discussed earlier, both of these models have support from mutation studies, 
particularly since the alteration of the residues corresponding to GluR-B Arg-506, Glu-726, 
Thr-501 and Glu-423 have been shown to affect receptor activation (Uchino et al., 1992; 
Wafford et al., 1995; Hirai et al., 1996; Kawamoto et al., 1997; Laube et al., 1997; Mano et 
al., 1996; Paas et al., 1996).  
The crystal structure of the GluR-B S1S2 also reveals that Lys-751 locating in the 
interdomain β-strand may be involved in control of domain closure and may therefore be 
important for receptor activation (Armstrong and Gouaux, 2000). Interestingly, in the apo-
state of the GluR-B S1S2 the interdomain Glu-726−Lys-751 bond blocks the binding site of 
the agonist α-amino group, while the interdomain Glu-726−Thr-676 bond blocks the binding 
site of the agonist γ-carboxyl group. Both these interdomain bonds stabilize the apo-state of 
the GluR-B binding domain in a way similar to that of the two interdomain bonds in the 
bacterial GluR0 S1S2 apo-state structure (Mayer et al., 2001). However, in the GluR0 those 
bonds do not involve the β-strand, nor do they block the binding site for the γ-carboxyl group 
of an agonist. Due to these differences in the apo-state stabilization, it has been suggested that 
the control of receptor activation is different in iGluRs and in GluR0  (Mayer et al., 2001). 
The poor stabilization of the apo-state of the GluR0 and possibly of the PBPs, may explain 
why both these proteins are found (in the crystal structures) in a closed conformation in the 
absence of the ligand as well as the open conformation (Flocco et al., 1994). The spontaneous 
cleft closure of GluR0 may also explain why the GluR0, but not the GluR-B receptors have 
been found to undergo spontaneous activation in the absence of ligand (Mayer et al., 2001).  
1.5.2 The activation-desensitization model 
Factors that can affect the kinetics and extent of AMPA receptor desensitization are; 
subunit composition of the receptor, type of bound agonist, alternative splicing affecting the 
flip/flop region and the RNA editing of the so-called R/G-site (reviewed in Dingledine et al., 
1999; Jonas, 2000). In addition, AMPA receptor desensitization can be modulated by some 
allosteric compounds (see chapter 1.2.4.). In general, the AMPA receptors carrying the flip-
segment in their subunits are desensitized more slowly than their equivalent flop-variants 
 38
(Mosbacher et al., 1994).  The flip/flop-segment also affects the sensitivity of the receptor to 
allosteric compounds like CTZ, aniracetam and PEPA (Partin et al., 1994; 1995; Johansen et 
al., 1995; Sekiguchi et al., 1997). For example, the blockage of AMPA receptor 
desensitization by CTZ has been shown by mutation analysis to be determined by Ser residue 
at position 771 of GluR-A flip-variant subunit (Partin et al., 1995; 1996; Johansen et al., 
1995). On the other hand, receptors which are composed of GluR-B-D subunits and carry the 
Gly residue at the R/G-site recover from desensitization faster than the unedited versions 
(Lomeli et al., 1994). Moreover, a single Leu residue in the S1 region of the GluR-A-D 
subunits is known to have strong effect on receptor desenzitization. Initially, the participation 
of this residue was demonstated by the GluR-C mutation L507Y, which was shown to block 
receptor desensitization completely (Stern-Bach et al., 1998). Another mutation study 
suggested that residue Tyr-716 in the GluR-Aflop subunit (homologous to Tyr-723 of the 
GluR-B subunit) determines the fast desensitization of the receptor composed of these 
subunits (Banke et al., 2001; see chapter 1.4.4).   
The publication of the crystal stucture of the GluR-B S1S2J provides a new aspect to 
the study of the desensitization mechanism. It was found that the S1S2 proteins formed 
dimers with 2-fold symmetry and most of the structural determinants of desensitization as 
revealed by mutation studies, were found at or near the dimer interface (Armstrong, 1998; 
2000). For example, Leu-504 (corresponding to Leu-507 of the GluR-C) locating in the helix 
D had hydrophobic contacts with residues in helix J of the other dimer. In addition, the 
flip/flop segment and the R/Q-site (located in helices J and K) were found to be at or near the 
dimer interface. Therefore, it seems that the interaction of helix D with helix J at a dimer 
interface participates in the regulation of receptor desensitization (Armstrong et al., 2000, 
Mayer et al., 2001). A recent mutation study of chimeric GluR-A and GluR6 subunits 
supports this view and suggests that the helices D, J and K are involved in regulation of 
desensitization through interface interaction. This study demonstrated that in addition to the 
residue corresponding to residue Leu-507 of the GluR-C, two previously unidentified residues 
in the flip/flop area and a new residue in the β-strand 7 contributed to the desensitization 
effect of CTZ  (Partin, 2001). 
  Strong support for the dimer interacting regulation was given by a recent crystal 
structure of the GluR-B S1S2J carrying a mutation at Leu-504 residue (Sun et al, 2002). The 
mutant protein formed a similar dimer interface to the one formed in the crystals of the wild-
type GluR-B S1S2J. However, the Tyr-504 introduced by mutation was able to form a more 
tightly stabilized dimer interface by contacts to residues Leu-769 and Lys-773 in the helix J 
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than the wild-type Leu-504. Since this mutation is also known to block AMPA receptor 
desensitization (Stern-Bach et al., 1998), it was suggested that an active state is favoured by 
stabilization of this interface (Sun et al., 2002). Moreover, a crystal structure of another 
mutant of GluR-B S1S2J (flop-N775S) in complex with CTZ revealed how the Ser residue at 
the Asn/Ser-site in the flip-segment of the AMPA receptor subunits makes receptor 
desensitization sensitive for the CTZ blockage. CTZ was bound between Ser-775 from helix J 
and the residues Pro-515, Phe-516 and Ser-518 from β-strand. In other words, by binding 
between the dimer interface, CTZ stabilizes the same interface structure that was also 
stabilized by Tyr in the L504Y S1S2 mutant protein.  Therefore, CTZ seems to prevent the 
receptor to enter a desensitized conformation in a similar manner to the previously mentioned 
L504Y mutation (Sun et al., 2002).  
Finally, the structure of a GluR-B S1S2J mutant flop-N775D revealed that the Asn 
residue at the Asn/Ser-site is located at the interface of a new type of a subunit-subunit dimer. 
This second type of dimer interface was suggested to be present when the receptor is in the 
desensitized state (Sun et al., 2002). This so-called ´later interface´ was shown in the crystal 
structure to involve the lobe 1 from one subunit and the lobe 2 from the other subunit (Fig. 7). 
Based on the previously mentioned two distinct interface structures, a recent 
activation-desensitization model suggests that the conformational shifts between the activated 
and the desensitized states are controlled by stabilization of these two interfaces (Sun et al., 
2002, reviewed in Madden, 2002). The model suggests that, in the apo-state conformation, the 
first type of dimer interface exists between lobe 1 of the dimer A and lobe 1 of dimer B. This 
interface remains unchanged when receptor is activated upon agonist binding, but lobe 1A is 
closed in respect to lobe 2A and the lobes 2A and 2B are separated from each other (Fig. 7). 
Activation also involves the channel opening due to a clockwise screw-axis movement of lobe 
up and away from the channel 4-fold symmetry axis, causing rotation of TM helices via 
connecting peptides (Armstrong et al., 2000, Mayer et al., 2001). On the other hand, when the 
receptor is desensitized the first type of interface between lobe1A and lobe1B is reorganized 
and lobe closure is decoupled from ion channel opening. This leads to the formation of the 
´later interface´ between the lobes (1A and 2C). This is achieved when lobes 1A -1B are 
separated from each other allowing lobes 2A and 2B to come close together. This new 
conformation allows the closed-cleft conformation around the agonist to stay unchanged, 
whilst the channel is closed (Sun et al., 2002). 
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Figure 7. Activation-desensitization model for the iGluRs. Labels D1 and D2 correspond to domain 1 
and domain 2 of each subunit. Cylinders illustrate the receptor channel and the circle between the binding lobes 
corresponds to the bound ligand. Ligand binding induces closure of domain 2 towards domain 1, however the 
dimer interface between the D1 and D2 of the two subunits is retained when the channel is opened. If activation 
leads to desensitization, the channel is closed and the D1−D1 interface is interrupted. In the desensitized state a 
new ´later interface´ is formed between D1 of one subunit and D2 of another subunit. (Adapted from Sun et al., 
2002.) 
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2 AIMS OF THE PRESENT STUDY 
 
The present study addressed the following questions: 
 
1. Is the ligand-binding domain of the GluR-D AMPA receptors structurally and 
functionally related to bacterial amino acid binding proteins? 
 
2. What are the roles of the conserved cysteines in the ligand-binding domain of the 
AMPA receptors? 
 
3. What are the structural determinants responsible for the specific binding of agonists 
and antagonists to the GluR-D AMPA receptors? 
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3 MATERIALS AND METHODS 
 
 
Method Original publication where methods and materials  
are described in 
Anion exchange chomatography∗ I 
Edman degradation∗ I 
Homology modelling∗ II 
Immunoaffinity chromatography I 
Ligand docking∗ III 
Ligand minimization∗ III 
Mass spectroscopy∗ I 
N-terminal sequencing∗ I 
Radioligand-binding assay -Equilibrium dialysis∗ I 
Radioligand-binding assay -Filter binding I-III 
Receptor minimization∗ III 
Recombinant baculovirus expression  I-III 
Protein labelling with thiol-specific reagents∗ I 
SDS-PAGE II-III 
SH-group titration∗ I 
Site-directed mutagenesis I-III 
Structural modelling∗ III 
V8- protease digestion∗ I 
Western blotting II-III 
∗ Methods that the author of the thesis has not utilized 
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4 RESULTS 
4.1 Expression of the soluble S1S2 ligand-binding domain 
The AMPA receptor ligand interactions were studied in the present work by using the 
GluR-D S1S2 fusion protein as a surrogate for the intact GluR-D receptor (I, II and III). As 
described previously, the protein was constructed by joining the ligand-binding regions (S1: 
residues 404-546 and S2: 649-813; numbering refer to amino acid residues of the rat GluR-D 
starting from the first translated residue; EMBL/GenBank accession No. M36421) of the 
GluR-D with a hydrophilic linker peptide (Kuusinen et al., 1995). Such fusion proteins of the 
GluR-D or -B lack the membrane-spanning segments and the N- and C-terminal domains of 
the receptor, but they can be expressed as soluble secreted proteins both in the baculovirus 
system and in the E.coli periplasm (Kuusinen et al., 1995; Arvola and Keinänen, 1996). 
Compared to the intact receptors the expression and purification of the S1S2 protein is less 
complicated due to its solubility. Moreover, the pharmacological profile of the S1S2 fusion 
protein is almost identical to that of the corresponding intact receptor (Kuusinen et al., 1995).    
The wild-type S1S2 protein and the S1S2 constructs carrying site-directed single 
amino acid mutations were expressed in Trihcoplusia ni High Five cells (I, II and III). The 
proteins carrying the N-terminal Flag and C-terminal myc epitopes were detected in the 
culture supernatant by Western blotting with the anti-Flag M1 antibody. Usually detection 
showed one 42-kDa band or in some cases a doublet of 40-kDa and 42-kDa species. Taking 
into account the possible presence of N-glycosylation on the two consensus sites at the N-
terminus of the S1, the sizes of the detected bands were close to the calculated size of 39 kDa 
of the S1S2 polypeptides. The 40- and 42-kDa bands likely represent different degrees of 
glycosylation of the S1S2 protein. The finding that the protein was soluble and secreted to the 
culture medium strongly suggested that the protein was correctly folded and the signal peptide 
was correctly processed. In most cases (II and III), the intensities of the mutant protein bands 
were similar to wild-type S1S2 proteins, suggesting that the mutations did not affect the level 
of expression. However, the single Cys mutants (C740S and C795S), and the douple Cys 
mutant (C740S/C795S) had a significantly lower expression level than the wild-type S1S2 (I: 
see Table III). The single mutants formed covalent oligomers which after treatment with DTT 
or β-mercaptoethanol appeared as monomers on SDS-PAGE. The douple mutant seemed to 
form noncovalent aggregates, which did not dissapper after treatment with the recucing 
agents, but were captured by 300-kDa cut-off filter.   
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4.2 Cysteine residues 
The amino acid sequence of the ligand-binding domain of all ionotropic glutamate 
receptor subunits contains three conserved cysteines. In the NMDA receptors two of these 
cysteines are known to be involved in modulation of receptor function by reducing agents 
(Sullivan et al., 1994). Such modulation is thought to involve the reversible formation and 
breakage of a disulfide bridge by oxidation and reduction. It is thought that formation of a 
disulfide bridge between two lobes of the ligand-binding domain would stabilize the unbound 
ligand conformation of the binding domain in all iGluRs (Sutcliffe et al., 1996). 
In order to study if the disulfide bridge is formed in the ligand-binding domain of the 
GluR-D, we analyzed the accessibility of the cysteines of the S1S2 wild-type protein to thiol-
specific reagents (I). In addition, we studied how disruption of such a disulfide bond would 
affect the binding affinity of the ligands by analyzing the ligand-binding properties of the 
cysteine-mutated S1S2 proteins (I). 
The potential existence of a disulfide bond was studied by reacting the SH groups of 
the proteins with hydrophobic 5,5´-dithiobis-(2-nitrobenzoic acid) (DTNB) under non-
reducing and reducing, denaturing conditions. From the reaction done under non-reducing 
conditions one molecule of DTNB/mol of S1S2 protein was detected in Ellman reaction, 
whereas three molecules of DTNB/mol of S1S2 protein were detected if the protein was 
reduced with 1,4-dithio-DL-threitol (DTT) before reaction with DTNB. These results suggest 
that the S1S2 has one disulfide bridge and one free cysteine. In addition, the accessibility of 
the free cysteine to DTNB or to the more hydrophobic n-octyl-5-dithio-2-nitrobenzoic acid 
(ODNB) was studied in native conditions. Under non-reducing, native conditions 0.1 
cysteines/molecule of S1S2 were detected by using DTNB, whereas 0.9 cysteines/S1S2 were 
detected with ODNB, suggesting that the free cysteine is partially buried in a hydrophobic 
environment. The accessibility of the disulfide bridge to the reducing agents was also studied 
under native conditions by reacting the S1S2 with DTT prior to reaction with DTNB. Only 
1.2 cysteines/S1S2 was detected, suggesting that the disulfide bridge is only 10% accessible 
to reduction by DTT in the native protein structure.  
The position of the disulfide bridge was confirmed by labelling the S1S2 protein with 
N –(1-pyrenyl)maleimide in two separate procedures. Firstly, only free cysteines were 
labelled; secondly, only the disulfide-bridge-forming cysteines were labelled. The separation 
of the V8-protease digested peptide mixture yielded one nonapeptide fragment from the 
mixture containing free cysteines labelled. Detection by matrix-assisted laser desorption 
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ionization mass spectroscopy (MALDI-MS) and N-terminal sequencing revealed that the 
peptide fragment had one Cys corresponding to Cys-447 of the intact GluR-D. (I: see Fig. 1). 
From the mixture with the labelled disulfide bridge-forming cysteines two major fractions 
were separated. Two cysteines were detected from these fractions at positions corresponding 
to Cys-740 and Cys-795 of the intact GluR-D.  
 The effect of the disulfide bond on ligand binding was analyzed by a radioligand-
binding assay of the S1S2 proteins carrying mutations C740S or C795S. In the filter-binding 
assay the wild-type S1S2 bound [3H]AMPA with a dissociation constant (Kd) value of 13.3 
nM, whereas the affinities of the mutants C740S and C795S were increased nearly 2-fold (Kd 
7.2 nM and 7.8 nM, respectively). Equilibrium dialysis analysis also showed that the binding 
affinity for [3H]glutamate was increased 2.4-fold in C740S; the affinity of the C795S mutant 
was not determined (I: see Table III.) However, the kainate affinities were slightly reduced 
(~1.7-fold) in both mutants as measured by competition filter-binding assay. Like the single 
mutants, the double mutant C740S/C795S showed an increased affinity (~2.5-fold) for 
[3H]AMPA in a filter-binding assay (unpublished result: Lampinen, et al). The binding 
affinity for [3H]glutamate could not be measured by equilibrium dialysis due to shortage of 
the pure S1S2 mutant protein. These results suggest that the receptor agonist affinities were 
reduced by formation of the disulfide-bond between Cys-740 and Cys-795. 
4.3 Charged residues  
Based on the similarities between the amino acid sequences of the iGluR ligand-
binding domain (S1S2) and the bacterial PBPs, it has been predicted that the mechanism of 
ligand binding could be similar in these proteins (Sutcliffe et al., 1996; Kawamoto et al., 
1997; Laube et al., 1997). We tested the hypothesis that the major binding pocket interactions 
with the ligand are conserved from bacterial proteins to glutamate receptors (II). Specifically, 
we selected candidate residues for agonist binding from sequence alignments with the 
LAOBP and HBP, and subjected these residues to point mutations. The key interaction in the 
LAOBP and HBP are made by the charged Arg-77 and Asp-161 residues with the oppositely 
charged α-carboxyl and α-amino group of their amino acid ligand (Oh et al., 1993; Oh et al., 
1994b; Yao et al., 1994). Due to the substantially low sequence homology, particularly of the 
S2 segment, to PBPs, manual adjustments of sequence alignment were used to maximize the 
similarities within short sequences. We also controlled for the correctness of our sequence 
alignment by mutating and analyzing several charged groups which could potentially align 
with the ligand-interacting residues of the LAOBP and HBP.  
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The Arg-507 residue, which is conserved among all iGluR subunits, aligned well with 
Arg-77 of the LAOBP and HBP. However, three other positively charged residues were also 
selected for mutation to test their possible interaction with either the α-carboxyl or γ-
carboxylate group of glutamate (II: see Fig. 1). The wild-type S1S2 protein had an affinity for 
[3H]AMPA of Kd 37 nM, whereas the conservative mutation of R507K resulted in a complete 
loss of specific [3H]AMPA binding in the saturation binding assay (II: see Table I). In our 
structural model of the GluR-D S1S2, the side-chain of Arg-507 formed hydrogen and ionic 
bonds with the α-carboxylate oxygens of the agonist (glutamate) in a similar manner to the 
bonds which are formed by Arg-77 of the LAOBP and HBP (II: see Fig. 4). None of the other 
mutations done to the other positively charged residues (Lys-431, Lys-432 and Lys-471) 
significantly altered the binding of [3H]AMPA to the mutant proteins. They also bound 
glutamate, kainate and DNQX with affinities similar to the wild-type protein. Only the 
mutation L471H slightly reduced binding affinities of [3H]AMPA and glutamate (Kd 90 nM 
and Ki [inhibition constant] 0.7 µM, respectively). However mutation of the same residue to 
Arg or Ala did not change the affinity for [3H]AMPA (II: see Table I).  
Three negatively charged residues were also mutated to test their possible role in 
agonist binding. The Glu-727 aligned (with some adjustments) with Asp-161 of the LAOBP 
and HBP (Oh et al., 1993; Oh et al., 1994b; Yao et al., 1994). This Glu residue is in all 
AMPA and kainate receptor subunits, whereas NMDA receptor subunits have negatively 
charged Asp residue (II: see Fig. 1). When the Glu-727 was mutated to a neutral aliphatic 
(Ala) or neutral polar residue (Gln, Ser) a complete loss of [3H]AMPA binding resulted (II: 
see Table I). However, substitution with the negatively charged (Asp) residue resulted in a 
slight (5-10-fold) increase in  [3H]AMPA affinity. Interestingly, the binding affinities for 
glutamate and kainate were decreased (10- and 1000-fold, respectively), whereas the affinity 
for the antagonist DNQX was increased (40-fold) for the E727D mutation. These findings 
suggest that the Glu-727 has an important role in the agonist binding and selectivity. In our 
model structure of the ligand-binding domain, Glu-727 formed hydrogen bonds and ionic 
interactions to the agonist α-amino group in the similar manner to which Asp-161 forms key 
interactions with the ligand in the LAOBP and HBP structures (II: see Fig. 4). The second 
negatively charged residue, Glu-710 also aligned near the Asp-161 of the PBPs and was 
mutated as a control. When Glu-710 was mutated into Asp or Ala, no significant changes in 
agonist affinities were detected. The third residue Glu-424, previously shown to contribute to 
agonist affinities of the iGluRs (Sutcliffe et al., 1996; Kyryatov et al., 1994), aligned with 
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residue Tyr-14 of the LAOBP , which contacts the distal group of the amino acid side chain. 
Of the mutants created, E424D, E424Q and E424A, only the first two showed a slightly (~5-
fold) reduced affinity for glutamate.  
In parallel with the charged residues, we mutated residue the Tyr-472, since the 
corresponding residue of the chicken kainate-binding protein has been shown to contribute to 
antagonist binding (Paas et al., 1996). The mutant Y472F showed reduced affinity for 
[3H]AMPA (~ 10-fold), whereas the affinities for the other agonists were similar to those of 
the wild-type protein. The affinity for DNQX was also reduced (∼4-fold). 
4.4 N-terminus of the S2 segment 
The iGluR N-terminal segment of the S1S2 is homologous to a region in some PBPs 
which interacts with amino acid ligands (Kang et al., 1991; Oh et al., 1993; Oh et al., 1994a; 
b; Yao et al., 1994). Since the binding partners for the glutamate α-carboxyl and α-amino 
groups were already predicted (II), we subjected seven amino acids (L672-K678) from this 
region to mutations, in order to find additional determinants of agonist and antagonist binding 
(III). All residues were substituted with a small neutral alanine residue in order to abolish 
specific interactions of the side chain residue but not to disturb the main chain folding. This 
region was later shown by the crystal structure of the GluR-B S1S2 ligand complexes 
(Armstrong et al., 1998; Armstrong and Gouaux, 2000) to correspond with residues that 
precede or form an α-helical structure (helix F). Those structures were also used to construct 
docking models of the GluR-D S1S2 with bound glutamate, kainate, AMPA and DNQX to 
interpret our binding data. The mutant proteins were analyzed in a similar manner to the 
earlier mutants. In addition, we now used a new antagonist [3H] Ro-48 8587, which was 
described to have nanomolar affinity to rat brain membranes (Mutel et al., 1998). Thus we 
could study the affinities of agonists and antagonists independently from the proteins ability 
to bind [3H]AMPA.   
Firstly, the binding of agonists were studied using [3H]AMPA and competitive 
displacement by unlabelled ligands. This revealed that the mutations L672A, G675A and 
T677A led to a complete loss of [3H]AMPA binding. At 100nM [3H]AMPA concentration, 
shown to be saturable for the wild-type S1S2 , no specific binding could be detected with 
these mutants (III: see Fig. 2). On the other hand, the three mutants D673A, S676A and 
K678A showed only a slightly decreased affinity for [3H]AMPA (Ki 65.1 nM, 92.6 nM and 
103 nM, respectively) and the mutant S674A had an affinity (Ki 32.6 nM) similar to the 
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affinity of the wild-type S1S2 protein (Ki 24.8 nM). The binding affinity for glutamate was 
also slightly decreased in the mutants D673A and K678A 
Secondly, the agonist affinities of all mutants were studied by competing the [3H] Ro-
48 8587 binding with unlabelled ligands.  In addition to the reduced [3H]AMPA binding 
affinity, the mutant L672A showed a remarkably reduced affinities for glutamate (~80-fold) 
and kainate (~25-fold). In the ligand-docking models, the selective loss of AMPA, kainate 
and glutamate affinity was shown to result from a loss of hydrophobic side-chain packing (III: 
see Fig. 4). In GluR-B a tyrosine residue (Tyr-723) is at the same position as Phe-724 of the 
GluR-D, and affects the orientation of residue Leu-671 which corresponds to Leu-672 in the 
GluR-D. The residue is found in two different orientations in the GluR-B S1S2 structure, one 
observed in the AMPA- and glutamate-bound complex and the other in the kainate-bound 
complex. In our GluR-D model, Leu-672 is suggested to be in a similar orientation to Leu in 
the stucture of GluR-B S1S2-kainate complex. In that orientation, Phe-724 is packed against 
Leu-672 enabling the formation of hydrophobic contacts between the side-chain of Leu-672 
and the hydrophobic parts of the agonist (IV: see Fig. 5). Thus, the affinity loss for AMPA is 
likely to be caused by a breakage of the hydrophobic contacts between AMPA methylene 
group and an aromatic part of the isoxazol ring with Leu-672. In the same way, the mutation 
to Ala would eliminate the binding of two methylene groups of glutamate with the side-chain 
of Leu-672. On the other hand, a bulky isoprenyl group of kainate would have favourable 
interactions with the small alanine side chain, consistent with the observed moderate decrease 
in the kainate-binding affinity of L672A.  
Although the mutation G675A led to a complete loss of [3H]AMPA binding, the [3H] 
Ro-48 8587 competition assays showed that this mutation led only to a slightly reduced 
binding affinity for kainate, whereas the affinity for glutamate was unchanged. Based on the 
AMPA docking model, the selective loss of AMPA affinity is due to one water molecule near 
Gly-675 (´w1´in Fig. 4d of IV), which is present only in the AMPA-complex. Hydrogen 
bonding of the water molecule to a negatively charged oxygen atom (at 3-position of the 
isoxazole ring) and to an α-carboxylate of AMPA would be lost when this water molecule is 
displaced by the introduction of the methyl group of Ala in the place of hydrogen of Gly. 
The mutant T677A, which did not bind [3H]AMPA, had a reduced affinity for all 
agonists tested in the [3H] Ro-48 8587 competition assay. The glutamate affinity was reduced  
~4000-fold and the kainate affinity ~15-fold (III: see Table I and II). In our agonist docking 
models, the side-chain, OH-group of Thr-677 forms hydrogen bonds with these agonists. 
Mutation T677A would lead to elimination of the contacts that the Thr residue makes with the 
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negatively charged oxygen attached to the isoxazole ring of AMPA and with the distal 
carboxylate groups of glutamate and kainate. Thus, resulting in the observed reduction in the 
binding affinities of these agonists. The large loss in AMPA affinity is logical as the hydroxyl 
group of the isoxazol ring makes the only contacts of AMPA with the helix F region. 
However, whilst glutamate has fewer points of contact with the binding pocket as compared 
to AMPA, it does interact with the helix F region. Thus explaining the strongly reduced 
binding of the T677A mutant for glutamate.  
Consistent with the observed minor changes in [3H]AMPA binding for the D673A, 
S674A and K678A mutants, the [3H] Ro-48 8587 competition assay showed that the affinities 
for glutamate and  kainate were unchanged or only slightly changed (III: see Table II). Our 
ligand docking models show that the side-chains of Asp-673, Ser-674 and Lys-678 point 
away from the binding cavity (III: see Fig. 4) The slightly changed binding affinities for 
agonists in the S676A mutant (III: Table I and II) were in agreement with the model where 
Ser-676 participates in agonist binding only via the main-chain amide nitrogen, which forms a 
hydrogen bond with the agonist distal anionic group (III: see Fig. 4).   
After examining the agonist binding properties, we determined the binding affinities 
for DNQX and [3H]Ro-48 8587 antagonists by inhibiting the [3H]Ro-48 8587 binding with 
unlabelled ligands. The antagonist [3H]Ro-48 8587 had a high-affinity to the wild-type GluR-
D S1S2 (Kd 15.6 nM) similar to the previously reported nanomolar affinity to rat brain 
membranes (Mutel et al., 1998). Strikingly, none of the Leu-672–Lys-678 mutants showed 
significantly altered affinity for [3H]Ro-48 8587. The affinity for the another antagonist, 
DNQX, was also unaffected in all the mutants tested. The unchanged affinities for antagonists 
DNQX and Ro-48 8587 were consistent with the docking model of the GluR-D S1S2 with 
bound DNQX and Ro-48 8587 (IV: see Fig. 6). In this model, DNQX does not make any 
close contacts with residues Leu-672–Lys-678 in helix F region. Similarly, Ro-48 8587 does 
not make any side-chain contacts with the helix F region, although the antagonist imidazolyl 
group may be hydrogen bonded to some main chain residues. 
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5 DISCUSSION 
In this study we have experimentally tested the hypothesis that AMPA receptors and 
PBPs may use similar mechanisms for binding their respective ligands. We performed site-
directed mutation analysis by using a S1S2 fusion protein as a surrogate for the intact receptor 
(Kuusinen et a., 1995, Arvola and Keinänen, 1996). In principle, mutations may affect ligand 
interactions by at least two distinct mechanisms. Firstly, a mutation may eliminate structures 
which directly participate in ligand binding. Secondly, a mutation may eliminate structures 
which are important for the folding and stability of the ligand-binding domain. A complete 
loss of ligand binding may reflect either of these two cases, whereas mutations that affect the 
binding of only specific ligands are more likely due to the former case. We studied the 
binding of different types of ligands and used molecular modelling in order to distinguish 
between the two mechanisms mentioned above. The results from the first part of this work 
predicted that the binding of ligands is indirectly affected by a disulfide bridge, which 
stabilizes the structure of the unliganded binding domain (apo-state) by connecting the two 
lobes of the domain. The results from the second and third parts of the present work predicted 
residues which directly form hydrogen bonds and ionic contacts with agonist or antagonist 
compounds. After publication of the first and second part of this work, the first crystal 
structure of the iGluR ligand-binding domain became available (Armstrong et al., 1998). 
Although, the mutations described in the III publication were designed before the structure 
was published, the analyses of the binding data were done with the help of the new models 
based on the newly available structural data. 
5.1 Disulfide bridge 
All subunits of the different iGluR subclasses carry three cysteine residues in their 
ligand-binding domain S1S2. By using biochemical analysis we demonstrated that two of 
these Cys residues in S2 segment form a disulfide bridge. By mutation analyses we showed 
that this disulfide bridge is able to modulate agonist binding affinities of the GluR-D S1S2 
protein. 
Analysis of the GluR-D S1S2 protein by redox agents and thiol specific reagents 
revealed that the disulfide bond is formed between Cys-740 and Cys-795, whereas the Cys-
447 is free. The bridge forming cysteines are at equivalent positions as Cys-726 and Cys-780 
in the NR1, which has previously been shown to be sensitive to the reducing agent DTT 
(Sullivian et al., 1994). DTT has also been show to modulate NMDA receptor function by 
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increasing receptor currents and by decreasing the EC50 value for agonists (Aizeman et al., 
1989; Köhler et al., 1994). A number of studies on the NMDA receptors have shown that 
receptor function can be affected by several other oxidizing or reducing agents or by the 
subunit composition (Aizeman et al., 1989; Gilbert et al., 1991; reviewed in Dingledine et al., 
1998). These finding have led to a suggestion that control of the redox-oxidation state of the 
NMDA receptors may serve as neuroprotective mechanism in pathological situations 
(reviewed in McBain and Mayer, 1994, Lipton et al., 1993). In our study, subjection of the 
GluR-D S1S2 to the reducing agent DTT identified for the first time that the actual target for 
DTT modulation is the disulfide bridge forming cysteines. Moreover, subjection of the GluR-
D S1S2 to DTT under native conditions revealed that the disulfide bridge is relatively 
inaccessible to redox modulation by DTT. This may explain the previous observation that 
AMPA receptors are not sensitive to potentiation by DTT (Aizeman et al., 1989; Terramani et 
al., 1988). It has been suggested that the insensitivity for DTT modulation depends on subunit 
composition, which would determine if a disulfide bridge could be formed (Gozlan and Ben-
Ari, 1995). However, our result suggest that AMPA receptors do have a disulfide bridge, but 
it is not accessible for particular reducing agents since it is buried in a hydrophobic 
environment. This means that the subunit composition might instead regulate the accessibility 
of the disulfide bridges to reducing agents. In that case the regulation of the redox state of the 
receptor could be controlled by regulation of subunit composition alone and the maintenance 
of appropriate redox state would not require active modulation in vivo as has been suggested 
(Gozlan and Ben-Ari, 1995). The finding that free cysteines were accessible to DTNB and 
ODNB to different extents revealed that the accessibility of the disulfide bridge and perhaps 
the modulation of redox state of different receptors are also dependent on the chemical nature 
of the reducing/oxidizing agent. 
The analysis of the single mutants C740S and C795S and the double mutant 
C740S/C795S by ligand-binding assays revealed that a disruption of the disulfide bridge 
resulted in an increase in the binding affinity of AMPA and in some cases an increase in the 
binding affinity of glutamate. These results were consistent with the previous mutation 
analysis, which showed that the mutation of C722S in the GluR-C led to an increased affinity 
for glutamate and to decreased channel conductivity (Watase et al., 1997). In addition, the 
usage of the soluble ligand-binding domain of the GluR-D in our studies revealed that 
changes in the EC50 or agonist affinities of intact receptors are due to changes in the free 
energy of ligand binding and not due to changes in the free energy of gating. In other words, 
the effect that DTT modulation has on ligand-binding affinity of the receptor can be mediated 
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by the ligand-binding domain S1S2 alone. We also found that the cysteine-mutated S1S2 
proteins were expressed at lower levels than the wild-type S1S2 proteins, and the double-
cysteine mutants formed aggregates, suggesting that the disulfide bridge is also important for 
the correct folding and the general stability and functionality of the ligand-binding domain. 
This finding is in agreement with a previous model of the GluR6 subunit, which suggested 
that the disulfide bridge stabilized the apo-state conformation  (Sutcliffe et al., 1996). That 
model was based on the predicted analogy to bacterial PBPs. They also have three cysteines 
although at positions distinct from the cysteines in the S1S2 structure. In the unliganded 
structures of several PBPs a disulfide bridge is formed between cysteines at two loop 
structures, which move apart from each other when ligand binding induces closing of the 
binding domain (Sutcliffe et al., 1996; Kang et al., 1991; Oh et al., 1993; Hsiao et al., 1996; 
Gozlan and Ben-Ari, 1996; Yao et al., 1994). After publication of our results, the crystal 
structure of the GluR-B S1S2 showed that the Cys residues at corresponding sites to Cys-740 
and Cys-795 of the GluR-D are at such distance that a disulfide bridge can be formed only if 
agonist is not bound (Armstrong et al., 1998; Armstrong and Gouaux, 2000). By connecting 
the two binding lobes of the ligand-binding domain the disulfide bond would favour the 
unliganded conformation, as strain would be introduced in the bound conformation. Thus, the 
structure also supports our finding that elimination of the bridge leads to increased agonist 
affinities, whereas the formation of a disulfide bridge leads to reduced agonist affinities.  
Despite the evidence showing formation of a disulfide bridge between the two lobes of 
the AMPA receptor ligand-binding domain, the involvement of this bond in redox modulation 
of native receptors is still unclear. The disulfide bond may be important for stabilization of the 
native structure in general, and that role alone might be enough to explain the conservation of 
this bond throughout the iGluR family. 
5.2 Charged residues in agonist binding   
By using sequence alignment of the GluR-D S1S2 with the HBP and LAOBP, 
followed by mutation analysis, we identified candidate residues which may interact with the 
shared α-aminocarboxylate core of the amino acid ligands of these proteins. Nonconservative 
mutations R507K and E727A,Q,S resulted in  a complete loss of detectable specific binding 
even at saturable (100 nM) concentration of [3H]AMPA. In our sequence alignment Arg-507 
aligned with Arg-77 of the LAOBP and HPB, which in their crystal structure makes ionic and 
hydrogen bond interactions with the α-carboxyl group of L-lysine and histidine ligands, 
respectively (LAOBP: Oh et al., 1993; Oh et al., 1994b; HBP: Yao et al., 1994). Our 
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molecular model suggested that in the GluR-D ligand-binding pocket the cationic side-chain 
group of the Arg-507 is at a suitable distance from the anionic α-carboxyl group of the 
agonist so that ionic and hydrogen bond interactions are formed between these groups. This 
interaction is logical since the Arg residue is conserved throughout the iGluR family and all 
iGluR agonists have a carboxyl moiety attached to α-carbon of amino acid compound. 
Previously, a number of point mutations have been done on subunits of vertebrate iGluRs in 
order to study the effect of mutation on receptor activation or on ligand-binding affinity (see 
Table II). The studies where GluR-A subunit residues equivalent to Arg-507 of GluR-D were 
replaced by Glu, Gln or Lys resulting in a totally abolished agonist binding to the receptor, led 
to a suggestion that this residue is essential for agonist binding either directly or indirectly 
(Uchino et al., 1992, see Table II: Kawamoto et al., 1997). In addition, in NMDA receptors 
residues equivalent to Arg-507 of GluR-D has been shown to be essential for binding of 
glycine to NR1 subunits or binding of agonist to NR2B subunit (Kuryatov et al., 1994; 
Wafford et al., 1995; Hirai et al., 1996, Laube et al., 1997). Based on these analyses, some 
earlier models already suggested that residues corresponding to Arg-507 of GluR-D would 
have interaction with the α-carboxyl of the agonist (Kawamoto et al., 1997; Laube et al., 
1997); whilst another model suggested that this Arg would interact with the γ-carboxyl group 
of the agonist. However, in the latter model the γ-carboxyl of the agonist is in a different 
orientation than the ligands bound to the LAOBP and HBP, thus making the α-carboxyl group 
a more reliable binding partner for Arg-507 (Sutcliffe et al., 1996). 
In the case of Glu-727 of the GluR-D, a comparison of the binding results from 
mutants E727D,A,Q,S showed that the negative charge at the position 727 is essential for the 
binding of agonist. The disruption of the negative charge by displacement of the Glu residue 
with residues Ala or Gln completely abolished the detectable [3H]AMPA binding, whereas 
displacement with a negatively charged Asp led to an increased affinity for AMPA and a 
decreased affinity for glutamate and kainate. Our molecular model demonstrated how the 
anionic side chain group of Glu-727 (carboxylate group) is involved in the formation of salt 
bridges and hydrogen bonds with the agonist α-amino group. We suggest that the mutation 
E727D causes slight changes in the positions of residues near the agonist and results in 
slightly better contacts with AMPA compound and worse contacts with glutamate and 
kainate. These results indicate for the first time that Glu-727 of the GluR-D corresponds to the 
Asp-161 of the HBP and LAOBP and that also the α-amino group of the ligand is bound by 
similar mechanism in both these proteins. This strongly supports the sequence homology-
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based prediction of the structural relationship between PBPs and the ligand-binding domains 
of iGluRs (Nakanishi et al., 1990; O´Hara et al., 1993). Although the residues corresponding 
to Glu-727 were not previously identified in binding of α-amino group of the agonist, some 
previous studies on equivalent residues suggests an essential role for this residue. Supporting 
our finding, a disruption of a negatively charged Glu residue (equivalent to Glu-727 of the 
GluR-D) by substitution with Gln or Ala was found to abolish kainate binding in the chicken 
KBP (Paas et al., 1996). In addition, substitution of the equivalent Asp residue of the NR1 
subunit with Gly, Ala or Glu strongly reduced the glycine sensitivity of the heteromeric 
NMDA receptor (Williams et al., 1996). 
Our prepictions that Arg-507 and Glu-727 are essential in the stabilization of the α-
carboxyl and α-amino groups of the agonists were subsequently confirmed by the 
determination of crystal structure of the GluR-B S1S2 in complex with ligands (Armstrong et 
al., 1998; Armstrong and Gouaux, 2000). The crystal structure also shows that the α-carboxyl 
and α-amino groups of the bound glutamate, AMPA or kainate form hydrogen bonds with 
side-chain or main-chain atoms of Thr-502, Ser-676 and with the main-chain of Pro-500. The 
interaction of glutamate with Pro-500 was also predicted in our model. Furthermore, a recent 
infrared spectroscopy measurements of the GluR-D S1S2 in the presence or absence of 
kainate or glutamate provided support for the proposal that Arg-507 and Thr-502 form 
hydrogen bonds to the α-carboxylate of the bound agonist, and that Glu-727 together with the 
backbone group of Pro-500 form hydrogen bonds to the α-amino groups of the agonist 
(Jayaraman et al., 2000). The crystal structure of the GluR-B S1S2 with bound ligands were 
also consistent with our results which showed that mutation of charged residues Lys-431, 
Lys-432, Lys-471 and Glu-710 of GluR-D S1S2 did not affect the binding of agonist of 
antagonist. As we suggested, the crystal structure showed that respective residues of GluR-B 
were not in direct contact with bound agonists or antagonists (Armstrong et al., 1998; 
Armstrong and Gouaux, 2000). However, some previous mutations of the GluR-A or -B (Li et 
al., 1995), NR1 or NR2 (Wafford et al., 1995, Laube et al., 1997; Anson et al., 1998) subunits 
on residues corresponding to Lys-471 of the GluR-D have shown to decrease agonist binding 
affinities.  
We also analyzed the role of Glu-424 of the GluR-D in ligand binding, since in some 
previous predictions the residues corresponding to Glu-424 has been suggested to be the 
counterpart for the α-amino group of agonist (Paas et al., 1996; Sutcliffe et al., 1996; Laube 
et al., 1997). Mutations at this position in the GluR-A subunit (Mano et al., 1996; Uchino et 
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al., 1992), in the NR1 and NR2 subunits (Kuryatov et al., 1994; Laube et al., 1997) and in the 
KBPs of goldfish and chicken (Wo and Oswald, 1996; Paas et al., 1996) have been shown to 
reduce sensitivity to agonist (Table II).  In addition, one recent study suggests that the residue 
the Glu-416 of GluR-A subunit (corresponding to Glu-424 of the GluR-D) participates 
directly in binding of willardiine agonists (Kizelsztein et al., 2000). However, our results 
strongly suggests that Glu-424 does not form any important polar contacts with AMPA, 
glutamate or kainate, since our mutant E424A showed unchanged binding affinity for 
[3H]AMPA and glutamate, and only slightly reduced affinity for kainate. In contrast to our 
results the crystal structure of the GluR-B S1S2 with bound agonists demonstrates that 
residue Glu-423 (corresponding to Glu-424 of the GluR-D) stabilizes the agonist-bound 
domain structure by forming an interdomain hydrogen bond E424-T707 (Armstrong et al., 
1998). However, we suggest that if such an interdomain hydrogen bond would be present in 
the GluR-D our results from mutant E424A should show significant decrease in agonist 
affinities. Yet, another indirect role for Glu-424 is suggested by a recent fluorescence titration 
studies with the GluR-D S1S2 proteins carrying mutations at position Glu-424 or Tyr-472 
(see Table II: Abele et al., 2000). In that study the residue Glu-424 is suggested to interact via 
a water molecule with the side-chain OH group of Tyr-472. The aromatic ring of Tyr-472 has 
direct hydrophobic interactions with agonists. The presence of a hydrogen bond between Glu-
424 and Tyr-472 is not supported by our results, since substitution of Tyr-472 with Phe in the 
GluR-D eliminated the side-chain OH-group of Tyr, however the mutation did not lead to any 
changes in glutamate or kainate affinity.  
5.3 Agonist vs. antagonist binding  
We identified three individual mutations (L672A, G675A and T677A) which 
selectively altered agonist binding but had unaltered antagonist affinities. Moreover, a further 
mutation (Y472F), which strongly reduced the affinity for the antagonist DNQX, whilst 
leaving most of the agonist affinities unaltered, was also identified.  
Replacement of Tyr-472 of the GluR-D S1S2 with Phe showed that DNQX and 
AMPA binding is affected by this residue. Affinities for AMPA and DNQX were reduced, 
whilst the affinities for kainate and glutamate were unchanged. Our molecular model 
predicted that the aromatic ring of Tyr-472 has favourable stacking interactions with the 
aromatic ring of DNQX. We further suggested that the hydroxyl group attached to the 
aromatic ring of Tyr-472 is important for the favourable orientation of that ring, since the 
elimination of the OH-group caused DNQX affinity to be reduced. Consistent with our 
 56
results, the subsequently published crystal structure of the GluR-B S1S2 in complex with 
DNQX showed that the aromatic ring of Tyr-471 (corresponding to Tyr-472 of the GluR-D) 
has favourable hydrophobic π-stacking interactions with the quinoxalinedione rings of DNQX 
in GluR-B (Armstrong and Gouaux, 2000). In addition, the crystal structure shows that Tyr-
471 makes only weak hydrophobic interactions with the isoprenyl group of kainate, which is 
consistent with the unaltered affinity for kainate in our Y472F mutant. Previously described 
mutation experiments have also shown that the Tyr residue at this position is involved in 
antagonist binding, since mutation of Tyr to Ile in the chicken KBP (Paas et al., 1996) or Tyr 
to Ser in the gold fish KBP (Wo and Oswald, 1996) led to a decreased interaction with 
CNQX.   
 The alanine scanning mutation of N-terminal S2 residues (Leu-672−Lys-678) showed 
that Leu-672, Gly-675, and Thr-677 participate selectively in agonists binding, but are not 
involved in binding of DNQX or Ro-48 8587 antagonists. The binding data was interpreted 
by constructing a ligand-docking model of the GluR-D S1S2 on the basis of the newly 
published crystal structure of the GluR-B S1S2 in complex with ligands. These new crystal 
structures also showed that the residues corresponding to the GluR-D Leu-672–Ser-674 form 
a loop structure and the residues corresponding to Gly-675–Lys-678 forms the N-terminal 
part of helix F in the GluR-B S1S2 structure (Armstrong et al., 1998; Armstrong and Gouaux, 
2000). The completely abolished affinity of T677A mutant for [3H]AMPA and reduced 
affinities for all agonists as tested by [3H]Ro-48 8587 competition assay were explained by 
the ligand docking models of the GluR-D S1S2. The docking models were almost identical to 
the template structures of the GluR-B S1S2 ligand complexes, since the amino acid sequence 
of the GluR-D and GluR-B subunits differ by only one residue within the S1S2 region. Both 
the GluR-D S1S2 model and the GluR-B S1S2 structure show that the side-chain OH-group 
of Thr-677 is hydrogen bonded to the γ-carbon substituents of kainate (carboxymethyl group) 
and glutamate (γ-carboxylate) and to the distal anionic group of AMPA (the hydroxyl group 
in the isoxazole ring of AMPA). Thus, the strongly reduced agonist affinities of the T677A 
mutant is well explained by the loss of hydrogen bonding between the distal anionic groups of 
the agonists and Thr-677. Consistent with our binding data, Thr-to-Ala mutations at this 
position have previously been shown to abolish kainate affinity for the chicken KBP (Paas et 
al., 1996) or to reduce glutamate affinity for NMDA receptors (Anson et al., 1998).  
The strongly reduced affinity for all agonists in the L672A mutant was explained by 
the loss of hydrophobic contacts in our ligand docking models of the GluR-D S1S2. These 
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agonist docking models are similar to the crystal structure of the GluR-B S1S2 in complex 
with kainate, whereas in glutamate complex the conformation of the side chain residue of 
Leu-672 is different. However, in the GluR-B S1S2 structure, Leu-671 clashes with the 
isoprenyl group of kainate preventing full closure of the ligand-binding domain. Whereas the 
Phe-724 in GluR-D (at position corresponding Tyr-723 of the GluR-B) packs against Leu-672 
and ideally orientates it to form hydrophobic interactions with AMPA, glutamate and kainate. 
It has been shown that Leu-688 to Val or Thr mutation leads to an increased affinity for 
kainate and Leu-688 to Ala mutation to a decreased sensitivity to glutamate desensitization 
(Mano et al., 1996) Based on these early findings and the crystal structures, it was suggested 
that the ligand-binding domain of kainate receptors is fully closed upon kainate binding due to 
the small Val residue at a position corresponding to Leu-672 in the GluR-D (Armstrong and 
Gouaux, 2000). This closure was suggested to explain the desensitization of kainate receptors 
by kainate activation, whereas AMPA receptors are not desensitized by kainate (Armstrong 
and Gouaux, 2000). However, our binding data suggests that even if the Ala side-chain 
introduced by mutation (L672A) would have favourable interactions with the isoprenyl group 
of kainate in the GluR-D S1S2, the loss of hydrophobic contacts with the Leu side-chain 
would probably favour the overall less stable closed-state structure.  
The Ala substitution of residue Gly-675 had a strikingly specific effect on the AMPA 
binding. The [3H]AMPA binding was totally abolished, whereas affinity for kainate was only 
moderately reduced and affinity for glutamate was unchanged. This specific effect on the 
AMPA binding was explained with the ligand-docking models, which indicate that a water 
molecule near the Gly-675 is only present in the AMPA complex. In the AMPA complex that 
water forms hydrogen bonds with the negatively charged hydroxyl group in the isoxazole ring 
of AMPA, the α-carboxylate of AMPA and the main-chain NH-group of Thr-677. Thus, the 
mutation of Gly-675 to Ala introduces an additional methyl side-chain group, which displaces 
the water molecule important for AMPA binding. Consistent with our results, a previous 
substitution of the Gly residue at this position with Ala in the NR2 subunit has been shown to 
remarkably reduce glutamate affinity of the NMDA receptor (Anson et al., 1998).  
Although the residues mentioned above specifically affected agonist binding, none of 
mutations at Leu-672–Lys-678 analyzed by ligand-binding assay with Ro-48 8587 or DNQX, 
affected antagonist binding. The DNQX docking model of the GluR-D S1S2 is identical to 
crystal structure of the GluR-B S1S2 and both show that the helix F region is not in contact 
with DNQX. Similarly, the docking of Ro-48 8587 showed no direct interactions with helix F. 
This suggests that the helix F region may not be involved in antagonist binding at all. Such a 
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selective participation of the helix F in agonist binding may have importance in receptor 
activation. In general, activation is thought to initially involve either large or more local 
conformational changes within the ligand-binding domains, which are then converted to 
conformational shifts of the channel forming segments (Abele et al., 1999; Madden, 2002; 
Arinaminpathy et al., 2002). The opening of the channel in receptor activation could be 
achieved by transmitting the conformational changes within the helix F region (Domain 2) to 
the M3 and M1 segments, since these membrane segments are directly linked to the helix F 
region and to C-terminus of the S1, respectively.  
On the other hand, in bacterial PBPs the ligand-binding role of the region 
corresponding to the helix F region is different. Although, the LAOBP and HBP  (Oh et al., 
1993; 1994a,b) have direct ligand interactions at the helix F region with residues 
corresponding to Leu-672 and Thr-677 of GluR-D, not all PBPs have ligand interactions with 
this region (Kang et al., 1991; Oh et al., 1993; 1994a,b; Yao et al., 1994; Hsiao et al., 1996, 
Sun et al., 1998). The agonists of the iGluRs have always an anionic group attached to the γ-
carbon, whereas the amino acid ligands of PBPs have largely variable side-chain residues. 
Due to this, both the binding mechanisms of side chain groups of the amino acid ligands of 
PBPs and the location of the binding site for these groups can vary greatly in PBPs (Mayer et 
al., 2001). Thus, the involvement of helix F may be important for iGluR activation, but the 
activation of bacterial PBPs (which are not connected directly to a channel) may not require 
contacts with the helix F region. 
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5.4 Conclusions 
In the present work, key residues involved in agonist binding were identified by 
combining analysis of ligand-binding properties of the mutated GluR-D S1S2 protein with 
molecular modelling of the binding-domain. Furthermore, mutation studies and protein 
chemical analysis demonstrated the presence of a disulfide bridge, which appears to be 
important for the stability of the ligand-binding domain structure. Overall, the present results 
provide support for a structural and functional relationship between bacterial amino acid 
binding proteins and the ligand-binding domain of ionotropic glutamate receptors. Despite the 
distinct functional roles of these proteins, they share a similar mechanism of ligand-binding 
and structural stabilization of the binding domain by a disulfide bond.  
The present work also demonstrates clear differences in the binding modes of agonists 
as compared to antagonists to the GluR-D. In particular, the residues in the helix F region 
have an important role in agonist vs. antagonist discrimination. Since the helix F region is 
adjacent to the channel forming segments, the identification of the agonist interactions within 
this region may have relevance in understanding the activation mechanism of the receptor. 
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 Table II. Residues important for ligand binding by ionotropic glutamate receptors 
 
 
Mutationb Location/functionc 
(crystal structure) 
GluR-B 
Equivalentd 
Effects of mutations 
on activitye 
Refs 
AMPA  receptors     
GluR-A E398Q Pocket/lobe-lobe 
contacts 
E423 13.5×↑ in Qius EC50; 15×less densitization in 
response to Qius 
10 
 Y446F Pocket/KA binding Y471 Less desensitization in response to Glu and Quis 
(not fully determined) 
 
 L646T Pocket/van der Waals 
contact with KA 
L671 20×↓in KA EC50  
 L646A  L671 More than 200×↓desensitization in response to 
Quis 
 
 S650V Glu, KA and AMPA 
binding 
S675 11.5×↑ in Quis EC50 ;more than 200×↓in 
desensitization in res ponse to Quis 
 
GluR-A E398K Pocket/lobe-lobe 
contacts 
E423 100 000×↑, 45×↑, 27×↑, 21×↑ in Glu, Quis, KA 
and AMPA EC50, respectively 
2,11 
 D443K Outside the pocket D468 5×↑, 5×↑, 4×↑, 3×↑ in Glu, AMPA, Quis and 
KA EC50 
 
 K445Q Outside the pocket K470 51×↑, 3×↑, 0×↑in AMPA, Glu and KA EC50  
 K445E  K470 22×↑, 17×↑,6×↑, 0×↑in Glu, Quis, AMPA and 
KA EC50 
 
 R481Q,K DNQX, KA, Glu and 
AMPA binding  
 Complete loss of channel activity and AMPA 
affinity 
 
GluR-A L497Y Far from the pocket L505 Complete block of desensitization 12 
GluR-B K449E Outside the pocket K470 3.5×↑ in Glu and KA EC50; no change in AMPA 
EC50;  
2 
GluR-C T504A DNQX, KA, Glu and 
AMPA binding 
T501 134×↑in Glu EC50 12 
 L507Y Far from the pocket L504 Complete loss of desensitization  
 L507S,T  L504 No change in desensitization response to Glu  
GluR-
Cflop
F728Y Pocket Y723 7×↑ in KA affinity, 33×↓ in (R,S)-BrHIBO 
affinity; and ∼WT affinity in Glu 
16 
 F728Y, 
G769R 
 Y723,G764 12×↑in KA affinity; 28×↓ in (R,S)-BrHIBO 
affinity and ∼WT affinity in Glu 
 
GluR-
Aflop 
Y716F Pocket Y723 14×↓ in KA affinity, 23×↑in (R,S)-BrHIBO 
affinity;  
16 
 Y716F, 
R757G 
 Y723,G764 19×↓ in KA affinity, 20×↑in (R,S)-BrHIBO 
affinity 
 
GluR-A A636T  Not in 3-d str 
(A643 in M3) 
200×↓ and 85×↓ in Glu and KA EC50 17 
GluR-Ao E398Q Pocket/lobe-lobe 
contacts 
E423 88×↑, 10×↑, and 2×↓ in 5H-willardiine, 5F-
willardiine and 5I-willardiine EC50; and ∼no 
change in 5Br-W and KA EC50 
15 
 Y446F Pocket/KA binding Y471 10×↑, 9×↑, 15×↑ and 3.6×↑ in H-W, F-W, Br-W 
and I-W EC50 and no change in  KA EC50 
 
 L646A Pocket/van der Waals 
contact with KA 
L671 247×↑, 67×↑,245×↑ and 2×↑ in H-W, F-W, Br-
W and I-W EC50 , respectively and no change in  
KA EC50 
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Mutationb Location/functionc 
(crystal structure) 
GluR-B 
Equivalentd 
Effects of mutations 
on activitye 
Refs 
 S650A Glu, KA and AMPA 
binding 
S675 ∼5×↑, ∼5×↑ and 2×↑ in H-W, Br-W and I-W 
EC50 and ∼no change in F-W and KA EC50 
 
GluR-D h E424D Pocket/lobe-lobe 
contacts 
E423 5×↓ and 2.5×↓ in Glu and KA affinities; and 
∼WT affinity in AMPA   
14 
 E424Q   28×↓ and 24×↓ in Glu and KA affinities and 
∼WT affinity in AMPA   
 
 K471H Outside the pocket K470 5×↓ and 4×↓ in Glu and AMPA affinitities and 
∼WT affinity to KA   
 
 K471A  K470 3×↓ in AMPA affinity and ∼WT affinities to Glu 
and KA   
 
 K471R  K470 No change in AMPA, Glu and KA affinities  
 Y472F Pocket/KA binding Y471 15×↓, 12×↓ and 2.3×↓ in AMPA, Glu and KA 
affinities 
 
 R507K DNQX, KA, Glu and 
AMPA binding 
R506 23000×↓ and 865×↓ in AMPA and Glu affinities  
 E727D Glu, KA and AMPA 
binding 
E726 2400×↓ and 56×↓ in KA and Glu affinities; ∼WT 
affinity to AMPA 
 
 E727A   25000×↓ and 41600×↓ in AMPA and Glu 
affinities  
 
 E727Q   AMPA no binding; Glu NB; and KA not 
determined 
 
      
GluR-D h E424D Pocket/lobe-lobe 
contacts 
E423 7×↓Glu affinity, ∼ no change in AMPA and KA 
affinity 
13 
 E424Q  E423 6×↓and 4×↓in Glu and KA affinities; AMPA 
affinity as WT 
 
 E424E Pocket/lobe-lobe 
contacts 
E423 6×↓ in KA affinity; no change Glu and AMPA 
affinities 
 
 K471R,A Outside the pocket K470 ∼No change in Glu, AMPA and KA affinities  
 K471H   4×↓and 2.5×↓ in Glu and AMPA affinities; KA 
affinity as WT 
 
 Y472F Pocket/KA binding Y471 10×↓ and 4×↓ in AMPA and DNQX affinities; 
∼no change in Glu and KA affinities 
 
 R507K DNQX, KA, Glu and 
AMPA binding 
R506 Complete loss of AMPA affinity  
 L672A Pocket L671 1750×↓, 77×↓ and 25×↓ in AMPA, Glu and KA 
affinities; DNQX and Ro 48-8587 affinities ∼WT 
 
 D673A Pocket D672 2.6×↓, 2-6×↓ and 2.2×↓ in AMPA, Glu and KA 
affinities; 1.6×↑ in Ro 48-8587 affinity; DNQX 
affinity ∼WT 
 
 S674A Pocket S673 1.3×↓ and 1.5×↓ in AMPA and Ro 48-8587 
affinities; no change in Glu, KA and DNQX 
affinities 
 
 G675A Pocket G674 225×↓ and 6×↓ in AMPA and KA affinities; Glu, 
DNQX and Ro 48-8587 affinities ∼WT  
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Mutationb Location/functionc 
(crystal structure) 
GluR-B 
Equivalentd 
Effects of mutations 
on activitye 
Refs 
 S676A Main chain contacts with 
KA ,Glu, AMPA  
S675 3.7×↓, 2-2.8×↓ and 1.6×↓ in AMPA, Glu and Ro 
48-8587 affinities; KA and DNQX affinities 
∼WT  
 
 T677A Side chain contacts with 
KA, Glu and AMPA  
T676  25000×↓, 3800×↓ and 13×↓ in AMPA, Glu and 
KA affinities; DNQX and Ro 48-8587 affinities 
∼WT  
 
 K678A Outside the pocket K677 4×↓, 2.4×↓ in AMPA and KA affinities; Glu, 
DNQX and Ro 48-8587 affinities ∼WT affinities  
 
 E727D Glu, KA and AMPA 
binding 
E726 840×↓ and 9×↓ in KA and Glu affinities; 8×↑ 
and 38×↑ in AMPA and DNQX affinities 
 
 E727Q,S,A  E726 Complete loss of AMPA affinity  
      
      
   
 
 
 
   
      
NMDA receptors     
NR1 Q387K Pocket/lobe–lobe 
contacts 
E423 14 000×↑in Gly EC50; 13×↑in Glu EC50 2,1 
 F390T,W,A,S Cleft 
 
Y426 35–63×↑in Gly EC50; ~no change in Glu EC50  
 Y392A Far from the pocket M428 12×↑in Gly EC50; ~no change in Glu EC50  
 D481N Outside the pocket D468 7×↑in Gly EC50; ~no change in Glu EC50  
 K465E  K470 420×↑in Gly EC50; ~5×↑in Glu EC50  
 K483Q  K470 125×↑in Gly EC50; ~no change in Glu EC50  
 K483A  K470 3×↑in Gly EC50; ~no change in Glu EC50  
 F466A,H Pocket/KA binding Y471 6300×↑and 2100×↑in Gly EC50; 10×↑and 3×↑in 
Glu EC50 
 
      
 F466Y  Y471 ~No change in Gly EC50; ~no change in Glu EC50  
      
 F515A Near (before) hinge1g F516 Complete loss of response to agonists  
 V666A Pocket L671 13×↑in Gly EC50; ~no change in Glu EC50  
 S669G Pocket G674 25×↑in Gly EC50; ~no change in Glu EC50  
 D732E, 
G,N,A 
Pocket/KA binding E726 4200–36 400×↑in Gly EC50; ~no change in Glu  
 F735A,S Near (before) hinge2g L748 16×↑and 23×↑in Gly EC50; ~no change in  
 F736A,S Near (before) hinge2 D749 28×↑in Gly EC50; ~no change in Glu EC50  
      
NR1 A714T Pocket/lobe–lobe 
contacts 
T707 4×↓in Gly EC50 3 
 A714C,F,E  T707 2–9×↑in Gly EC50  
 A714K,Y,V  T707 14–16×↑in Gly EC50  
 A714I,Q,R,L  T707 34–62×↑in Gly EC50; A714L, no change in Glu  
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Mutationb Location/functionc 
(crystal structure) 
GluR-B 
Equivalentd 
Effects of mutations 
on activitye 
Refs 
      
NR2B E387A Pocket/lobe–lobe 
contacts 
E423 237×↑in Glu EC50; no change in Gly EC50 1 
 F390S Cleft Y426 47×↑in Glu EC50; no change in Gly EC50  
 K459E Outside the pocket K470 180×↑in Glu EC50; no change in Gly EC50  
 H460F Pocket/KA binding Y471 9×↑in Glu EC50; no change in Gly EC50  
 S486A Pocket/KA binding P499 43×↑in Glu EC50; no change in Gly EC50  
 R493K Pocket/KA binding R506 Complete loss of response to agonists  
 V660A Pocket L671 18×↑in Glu EC50; no change in Gly EC50  
 S664G Pocket/KA binding S675 118×↑in Glu EC50; no change in Gly EC50  
 V709A Pocket M729 27×↑in Glu EC50; no change in Gly EC50  
      
NR2A N463A Outside the pocket D468 6×↑in Glu EC50 4 
 K465E Outside the pocket K470 10×↑in Glu EC50  
 H466A Pocket/KA binding Y471 216×↑in Glu EC50  
 H466F  Y471 13×↑in Glu EC50  
 T665A Outside the pocket T670 7×↑in Glu EC50  
 V666A Pocket L671 12×↑in Glu EC50  
 G669A Pocket G674 320×↑in Glu EC50  
 T671A Pocket/KA binding T676 1030×↑in Glu EC50  
      
Kainate receptors     
CKBP E33V Pocket/lobe–lobe 
contacts 
E423 112×↓in KA affinity; no change in Glu affinity 5 
 Y36F Cleft Y426 30×↓in Glu affinity; 5×↓in KA affinity  
 Y36I  Y426 Complete loss of KA affinity  
 K72A,S Outside the pocket K470 No change in KA and Glu affinities  
 Y73I Pocket/KA binding Y471 90×↓in Glu affinity; 10×↓in KA affinity;  
    >250-fold ↓in CNQX affinity  
 P100A Pocket/KA binding P499 10×↓in CNQX affinity; no change in KA and 
Glu affinities 
 
      
 T102A Pocket/KA binding T501 100×↓in Glu affinity; 58×↓in KA affinity  
 R107S Pocket/KA binding R506 Complete loss of KA affinity  
 S266A Pocket G674 5.5×↓in KA affinity; no change in Glu affinity  
 S267A Pocket/KA binding S675 5×↓in KA affinity; no change in Glu affinity  
 T268A Pocket/KA binding T676 Complete loss of KA affinity  
 Y299A Pocket/lobe–lobe 
contacts 
T707 5.8×↓in KA affinity; no change in Glu affinity  
 E316A Pocket/KA binding E726 Complete loss of KA affinity  
 F342I Hinge 2–Pocket Y753 Complete loss of KA affinity  
      
GFKARb Q12E Pocket/lobe–lobe 
contacts 
E423 5×↑in Glu affinity; ~no change in KA affinity 6 
 A51K Outside the pocket K470 13×↓in Glu affinity; 2.6×↓in KA affinity  
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Mutationb Location/functionc 
(crystal structure) 
GluR-B 
Equivalentd 
Effects of mutations 
on activitye 
Refs 
 Y52S Pocket/KA binding Y471 >100-fold ↓in KA affinity; .40-fold↓in CNQX 
affinity 
 
      
 Y52F  Y471 Slight ↓in KA affinity; no change in Glu affinity  
 C305S S–S bridge (see text) C739 3.5×↑in KA affinity Loss of binding modulation} 
12×↑in KA affinity {under redox conditions 
 
 C358S S–S bridge (see text) C794 5×↑in Glu affinity; ~no change in KA affinity  
      
GluR5 S721N Pocket/lobe–lobe 
contacts 
T707 Drastic loss of sensitivity to AMPA and 
iodowillardiine 
7,8 
      
GluR6 A689S Pocket/KA binding S675 Slower desensitization rate in response to KA 7,8 
 N721S Pocket/lobe–lobe 
contacts 
T707 Becomes responsive to AMPA and 
iodowillardiine 
 
 
 
The table is modified from Paas et al., (2000) Abbreviations: AMPA: α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid; CNQX: 6-cyano-7-nitroquinoxaline-2,3-dione; DNQX: 6,7-
dinitroquinoxaline-2,3-dione; GFKAR: gold fish kainite binding receptor Glu: glutamic acid; KA: kainic acid;  
Quis: quisqualate; W: willardiine. 
a The effects of mutations were examined using homo-oligomeric receptor assemblies with the 
exception of the NMDA receptors, and GluR-B (which was assembled with GluR-A) and study of GluR-
A/GluR-C chimeras by Banke et al, 2001 (ref, 16). b In some cases the amino acid numbers include the signal 
peptide. c ’Location’ corresponds to the place of the native amino acid in the crystal structures. The term ‘pocket’ 
means that the amino acid lines the water-accessible surface of the ligand-binding pocket. The term ‘cleft’ means 
that the residue is projecting into the interlobe cleft but does not necessarily contribute to the water-accessible 
surface of the pocket. The specific chemical interactions between ligands and receptor subunits are provided in 
Ref. Armstrong, N. et al (1998) (the crystal structure). d The numbering of GluR-B S1S2 residues include the 
signal peptide; the equivalence is according to the sequence alignment presented by Armstrong et al. 1998. e 
Activity is determined by measurements of: (1) flow of ionic currents through open channels (EC50 is the 
agonist concentration that gives half-maximal response); (2) desensitization (closure of channels) following 
agonist-elicited responses; and (3) ligand-binding affinity by monitoring the binding of radiolabelled ligands to 
the receptor and/or inhibition of radiolabelled ligand binding by unlabelled ligands. f K70 is located in loop 2 and 
its side-chain projects out of the ligand-binding pocket. However, it is very close to D672 and S673, which 
belong to the lower lobe, and thus, its substitution might interfere with the degree of lobe closure necessary for 
tight accommodation of Glu and AMPA. g Hinges 1 and 2 of GluR-B-S1S2 are formed by β-strands 7 and 12, 
respectively (Armstrong et al. 1998). h Water-soluble S1S2 fragment of GluR-D was used in this study 
(Lampinen et al. 1998). 1.  Laube et.al., 1997.  2.  Dingledine et al., 1999.   3. Wood et al., 1997.   4.  Anson et 
al., 1998.   5.  Paas et al., 1996.   6.  Wo and Oswald, 1996.   7.  Swanson, et al., 1997.   8. Swanson et al., 1998.  
10.  Mano et al., 1996.    11.  Kawamoto et al., 1997. 12. Stern-Bach et al., 1998.   13.  Lampinen et al., 1998.   
14.  Abele et al., 2000.  15.  Kizelstein et al., 2000.  16.  Banke et al., 2001.  17. Taverna et al., 2000.  
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